| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | syntaxin binding | 4.16e-05 | 87 | 214 | 7 | GO:0019905 | |
| GeneOntologyMolecularFunction | importin-alpha family protein binding | 6.65e-05 | 21 | 214 | 4 | GO:0061676 | |
| GeneOntologyMolecularFunction | protein phosphatase binding | CEACAM5 MFHAS1 CEACAM8 CEACAM6 CEACAM1 ITPR1 JAK3 MET KCNN4 ANK1 | 9.32e-05 | 210 | 214 | 10 | GO:0019903 |
| GeneOntologyMolecularFunction | GPI anchor binding | 9.68e-05 | 23 | 214 | 4 | GO:0034235 | |
| GeneOntologyMolecularFunction | calmodulin binding | CEACAM5 IQCF1 OBSCN CEACAM8 CEACAM6 DAPK1 CEACAM1 PHKB KCNN4 CASK | 1.96e-04 | 230 | 214 | 10 | GO:0005516 |
| GeneOntologyMolecularFunction | filamin binding | 2.47e-04 | 29 | 214 | 4 | GO:0031005 | |
| GeneOntologyMolecularFunction | granulocyte colony-stimulating factor receptor binding | 4.05e-04 | 14 | 214 | 3 | GO:0005130 | |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 4.62e-04 | 34 | 214 | 4 | GO:0015125 | |
| GeneOntologyMolecularFunction | phosphatase binding | CEACAM5 MFHAS1 CEACAM8 CEACAM6 CEACAM1 ITPR1 JAK3 MET KCNN4 ANK1 | 5.84e-04 | 264 | 214 | 10 | GO:0019902 |
| GeneOntologyMolecularFunction | SNARE binding | 6.69e-04 | 136 | 214 | 7 | GO:0000149 | |
| GeneOntologyBiologicalProcess | regulation of hepatocyte proliferation | 2.43e-06 | 38 | 214 | 6 | GO:2000345 | |
| GeneOntologyBiologicalProcess | meiotic chromosome segregation | 5.21e-06 | 122 | 214 | 9 | GO:0045132 | |
| GeneOntologyBiologicalProcess | endoplasmic reticulum to Golgi vesicle-mediated transport | LRRK2 GOLGA6B GOLGA6A ANK1 GOLGA6C GOLGA6D ERGIC1 SEC22C TRAPPC10 HTT | 6.51e-06 | 159 | 214 | 10 | GO:0006888 |
| GeneOntologyBiologicalProcess | epithelial cell proliferation involved in liver morphogenesis | 7.70e-06 | 46 | 214 | 6 | GO:0072575 | |
| GeneOntologyBiologicalProcess | hepatocyte proliferation | 7.70e-06 | 46 | 214 | 6 | GO:0072574 | |
| GeneOntologyBiologicalProcess | organelle inheritance | 9.28e-06 | 28 | 214 | 5 | GO:0048308 | |
| GeneOntologyBiologicalProcess | Golgi inheritance | 9.28e-06 | 28 | 214 | 5 | GO:0048313 | |
| GeneOntologyBiologicalProcess | negative regulation of brown fat cell proliferation | 1.04e-05 | 14 | 214 | 4 | GO:0070348 | |
| GeneOntologyBiologicalProcess | liver morphogenesis | 1.12e-05 | 49 | 214 | 6 | GO:0072576 | |
| GeneOntologyBiologicalProcess | regulation of brown fat cell proliferation | 1.41e-05 | 15 | 214 | 4 | GO:0070347 | |
| GeneOntologyBiologicalProcess | positive regulation of homophilic cell adhesion | 1.41e-05 | 15 | 214 | 4 | GO:1903387 | |
| GeneOntologyBiologicalProcess | insulin receptor internalization | 1.86e-05 | 16 | 214 | 4 | GO:0038016 | |
| GeneOntologyBiologicalProcess | brown fat cell proliferation | 2.41e-05 | 17 | 214 | 4 | GO:0070342 | |
| GeneOntologyBiologicalProcess | insulin catabolic process | 2.41e-05 | 17 | 214 | 4 | GO:1901143 | |
| GeneOntologyBiologicalProcess | meiotic cell cycle process | GOLGA6B GOLGA6A FANCA AGO4 MOV10L1 NCAPD2 SUN1 GOLGA6C GOLGA6D MEI1 SMC2 MAEL | 2.50e-05 | 268 | 214 | 12 | GO:1903046 |
| GeneOntologyBiologicalProcess | renal system process | 2.62e-05 | 149 | 214 | 9 | GO:0003014 | |
| GeneOntologyBiologicalProcess | regulation of homophilic cell adhesion | 3.08e-05 | 18 | 214 | 4 | GO:1903385 | |
| GeneOntologyBiologicalProcess | Golgi disassembly | 3.08e-05 | 18 | 214 | 4 | GO:0090166 | |
| GeneOntologyBiologicalProcess | intracellular transport | MKKS RAMP2 LRRK2 PEX6 GOLGA6B GOLGA6A HNF4A LYST NUP205 RAB28 ADIPOQ MDN1 EIF4ENIF1 COMMD1 AGT NFKBIA HERC2 CLEC16A KLC3 FBXW11 ANK1 NSF SUN1 HMGXB4 GOLGA6C GOLGA6D ANKRD50 ERGIC1 SEC22C NUP133 TRAPPC10 SERAC1 HTT | 3.11e-05 | 1496 | 214 | 33 | GO:0046907 |
| GeneOntologyBiologicalProcess | meiotic spindle organization | 3.82e-05 | 37 | 214 | 5 | GO:0000212 | |
| GeneOntologyBiologicalProcess | positive regulation of protein glycosylation | 3.86e-05 | 19 | 214 | 4 | GO:0060050 | |
| GeneOntologyBiologicalProcess | endothelial cell differentiation | 4.16e-05 | 158 | 214 | 9 | GO:0045446 | |
| GeneOntologyBiologicalProcess | meiotic nuclear division | GOLGA6B GOLGA6A FANCA AGO4 MOV10L1 SUN1 GOLGA6C GOLGA6D MEI1 SMC2 MAEL | 4.41e-05 | 240 | 214 | 11 | GO:0140013 |
| GeneOntologyBiologicalProcess | negative regulation of hepatocyte proliferation | 4.79e-05 | 20 | 214 | 4 | GO:2000346 | |
| GeneOntologyBiologicalProcess | positive regulation of sterol transport | 5.62e-05 | 40 | 214 | 5 | GO:0032373 | |
| GeneOntologyBiologicalProcess | positive regulation of cholesterol transport | 5.62e-05 | 40 | 214 | 5 | GO:0032376 | |
| GeneOntologyBiologicalProcess | Golgi vesicle transport | LRRK2 GOLGA6B GOLGA6A COMMD1 ANK1 NSF GOLGA6C GOLGA6D ERGIC1 PHAF1 SEC22C TRAPPC10 HTT | 5.75e-05 | 339 | 214 | 13 | GO:0048193 |
| GeneOntologyBiologicalProcess | negative regulation of fat cell proliferation | 5.87e-05 | 21 | 214 | 4 | GO:0070345 | |
| GeneOntologyBiologicalProcess | negative regulation of granulocyte differentiation | 7.12e-05 | 22 | 214 | 4 | GO:0030853 | |
| GeneOntologyBiologicalProcess | regulation of glycoprotein biosynthetic process | 8.09e-05 | 69 | 214 | 6 | GO:0010559 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet aggregation | 8.55e-05 | 23 | 214 | 4 | GO:0090331 | |
| GeneOntologyBiologicalProcess | Golgi ribbon formation | 8.55e-05 | 23 | 214 | 4 | GO:0090161 | |
| GeneOntologyBiologicalProcess | nephron development | 8.78e-05 | 174 | 214 | 9 | GO:0072006 | |
| GeneOntologyBiologicalProcess | regulation of protein glycosylation | 1.02e-04 | 24 | 214 | 4 | GO:0060049 | |
| GeneOntologyBiologicalProcess | positive regulation of vasculogenesis | 1.02e-04 | 24 | 214 | 4 | GO:2001214 | |
| GeneOntologyBiologicalProcess | organelle fission | LRRK2 GOLGA6B GOLGA6A FANCA MET AGO4 MOV10L1 NCAPD2 MIEF2 SUN1 GOLGA6C GOLGA6D MEI1 SMC2 USP16 CHEK2 MAEL | 1.02e-04 | 571 | 214 | 17 | GO:0048285 |
| GeneOntologyBiologicalProcess | gland morphogenesis | 1.04e-04 | 178 | 214 | 9 | GO:0022612 | |
| GeneOntologyBiologicalProcess | regulation of fatty acid biosynthetic process | 1.11e-04 | 73 | 214 | 6 | GO:0042304 | |
| GeneOntologyBiologicalProcess | negative regulation of protein binding | 1.20e-04 | 106 | 214 | 7 | GO:0032091 | |
| GeneOntologyBiologicalProcess | epithelial cell development | NUP210L DACT2 MET FASN ADIPOQ AGT KCNMA1 DMD RAPGEF1 EDNRB HYDIN | 1.22e-04 | 269 | 214 | 11 | GO:0002064 |
| GeneOntologyBiologicalProcess | endothelium development | 1.24e-04 | 182 | 214 | 9 | GO:0003158 | |
| GeneOntologyBiologicalProcess | renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure | 1.25e-04 | 10 | 214 | 3 | GO:0001999 | |
| GeneOntologyBiologicalProcess | ERK1 and ERK2 cascade | EPOR NLRP12 CEACAM5 MFHAS1 CEACAM8 CEACAM6 NDRG2 ABCA7 CEACAM1 ADIPOQ AGT SEMA6A DMD RAPGEF1 | 1.27e-04 | 418 | 214 | 14 | GO:0070371 |
| GeneOntologyBiologicalProcess | chromosome organization involved in meiotic cell cycle | 1.29e-04 | 75 | 214 | 6 | GO:0070192 | |
| GeneOntologyBiologicalProcess | protein homotetramerization | 1.49e-04 | 77 | 214 | 6 | GO:0051289 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | DCHS2 CEACAM5 CDHR2 CEACAM8 CEACAM6 CEACAM1 HMCN2 PCDHB2 DCHS1 | 1.52e-04 | 187 | 214 | 9 | GO:0007156 |
| GeneOntologyBiologicalProcess | regulation of fat cell proliferation | 1.64e-04 | 27 | 214 | 4 | GO:0070344 | |
| GeneOntologyBiologicalProcess | Golgi localization | 1.64e-04 | 27 | 214 | 4 | GO:0051645 | |
| GeneOntologyBiologicalProcess | positive regulation of cholesterol efflux | 1.64e-04 | 27 | 214 | 4 | GO:0010875 | |
| GeneOntologyBiologicalProcess | negative regulation of autophagy | 1.69e-04 | 112 | 214 | 7 | GO:0010507 | |
| GeneOntologyBiologicalProcess | serine transport | 1.71e-04 | 11 | 214 | 3 | GO:0032329 | |
| GeneOntologyBiologicalProcess | regulation of glycoprotein metabolic process | 1.84e-04 | 80 | 214 | 6 | GO:1903018 | |
| GeneOntologyBiologicalProcess | endothelial cell development | 1.84e-04 | 80 | 214 | 6 | GO:0001885 | |
| GeneOntologyBiologicalProcess | meiotic spindle assembly | 1.90e-04 | 28 | 214 | 4 | GO:0090306 | |
| GeneOntologyBiologicalProcess | negative regulation of homotypic cell-cell adhesion | 1.90e-04 | 28 | 214 | 4 | GO:0034111 | |
| GeneOntologyBiologicalProcess | regulation of ERK1 and ERK2 cascade | EPOR NLRP12 CEACAM5 MFHAS1 CEACAM8 CEACAM6 NDRG2 ABCA7 CEACAM1 ADIPOQ SEMA6A DMD RAPGEF1 | 2.04e-04 | 385 | 214 | 13 | GO:0070372 |
| GeneOntologyBiologicalProcess | regulation of vasculogenesis | 2.18e-04 | 29 | 214 | 4 | GO:2001212 | |
| GeneOntologyBiologicalProcess | sexual reproduction | MKKS NUP210L IQCF1 LRRK2 GOLGA6B GOLGA6A AK7 ITPR1 FANCA AGO4 DHH AGT MOV10L1 NCAPD2 HERC2 KLC3 FBXW11 ZMYND15 CFAP47 DNHD1 SUN1 GOLGA6C GOLGA6D MEI1 SMC2 SLC4A2 MAEL HTT | 2.28e-04 | 1312 | 214 | 28 | GO:0019953 |
| GeneOntologyBiologicalProcess | response to mechanical stimulus | 2.69e-04 | 247 | 214 | 10 | GO:0009612 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet activation | 2.85e-04 | 31 | 214 | 4 | GO:0010544 | |
| GeneOntologyBiologicalProcess | negative regulation of response to external stimulus | NLRP12 EPPK1 CEACAM5 MFHAS1 CEACAM6 CEACAM1 SERPINB9 ADIPOQ ADAMTS18 NLRC5 C5 CACNB3 AOAH CASK SIGLEC7 | 2.93e-04 | 509 | 214 | 15 | GO:0032102 |
| GeneOntologyBiologicalProcess | meiotic cell cycle | GOLGA6B GOLGA6A FANCA AGO4 MOV10L1 NCAPD2 SUN1 GOLGA6C GOLGA6D MEI1 SMC2 MAEL | 3.11e-04 | 350 | 214 | 12 | GO:0051321 |
| GeneOntologyBiologicalProcess | nuclear division | GOLGA6B GOLGA6A FANCA MET AGO4 MOV10L1 NCAPD2 SUN1 GOLGA6C GOLGA6D MEI1 SMC2 USP16 CHEK2 MAEL | 3.11e-04 | 512 | 214 | 15 | GO:0000280 |
| GeneOntologyBiologicalProcess | fat cell proliferation | 3.23e-04 | 32 | 214 | 4 | GO:0070341 | |
| GeneOntologyBiologicalProcess | negative regulation of feeding behavior | 3.64e-04 | 33 | 214 | 4 | GO:2000252 | |
| GeneOntologyBiologicalProcess | regulation of granulocyte differentiation | 3.64e-04 | 33 | 214 | 4 | GO:0030852 | |
| GeneOntologyBiologicalProcess | male gamete generation | MKKS NUP210L IQCF1 LRRK2 AK7 FANCA AGO4 DHH MOV10L1 HERC2 KLC3 ZMYND15 CFAP47 DNHD1 SUN1 MEI1 SLC4A2 MAEL HTT | 3.90e-04 | 762 | 214 | 19 | GO:0048232 |
| GeneOntologyBiologicalProcess | male meiotic nuclear division | 3.94e-04 | 60 | 214 | 5 | GO:0007140 | |
| GeneOntologyBiologicalProcess | granulocyte differentiation | 3.94e-04 | 60 | 214 | 5 | GO:0030851 | |
| GeneOntologyBiologicalProcess | monocarboxylic acid biosynthetic process | CEACAM5 CEACAM8 CEACAM6 HNF4A CEACAM1 FASN AGT DSE DAGLB HTT | 4.04e-04 | 260 | 214 | 10 | GO:0072330 |
| GeneOntologyBiologicalProcess | asymmetric cell division | 4.09e-04 | 34 | 214 | 4 | GO:0008356 | |
| GeneOntologyBiologicalProcess | negative regulation of vascular permeability | 4.09e-04 | 34 | 214 | 4 | GO:0043116 | |
| GeneOntologyBiologicalProcess | cilium movement | 4.16e-04 | 261 | 214 | 10 | GO:0003341 | |
| GeneOntologyBiologicalProcess | regulation of lipid metabolic process | CEACAM5 CEACAM8 CEACAM6 HNF4A ABCA7 CEACAM1 ADIPOQ DHH AGT KCNMA1 DAGLB RNF213 RORC | 4.18e-04 | 415 | 214 | 13 | GO:0019216 |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immune response to tumor cell | 4.57e-04 | 15 | 214 | 3 | GO:0002856 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 4.57e-04 | 15 | 214 | 3 | GO:0002859 | |
| GeneOntologyBiologicalProcess | insulin metabolic process | 4.58e-04 | 35 | 214 | 4 | GO:1901142 | |
| GeneOntologyBiologicalProcess | negative regulation of ERK1 and ERK2 cascade | 4.69e-04 | 95 | 214 | 6 | GO:0070373 | |
| GeneOntologyBiologicalProcess | developmental process involved in reproduction | MKKS EPOR NUP210L IQCF1 LRRK2 HNF4A AK7 FANCA AGO4 DHH AGT MOV10L1 HERC2 KLC3 CNTFR FBXW11 ZMYND15 CFAP47 DNHD1 SUN1 ID4 MEI1 SLC4A2 DACH2 MAEL HTT | 4.76e-04 | 1235 | 214 | 26 | GO:0003006 |
| GeneOntologyBiologicalProcess | regulation of fatty acid metabolic process | 5.06e-04 | 134 | 214 | 7 | GO:0019217 | |
| GeneOntologyBiologicalProcess | positive regulation of glycoprotein biosynthetic process | 5.12e-04 | 36 | 214 | 4 | GO:0010560 | |
| GeneOntologyBiologicalProcess | kidney development | DCHS2 LRRK2 DACT2 SULF2 ADIPOQ CLCNKA AGT TIMELESS C5 EDNRB NUP133 DCHS1 | 5.36e-04 | 372 | 214 | 12 | GO:0001822 |
| GeneOntologyBiologicalProcess | negative regulation of wound healing | 5.54e-04 | 98 | 214 | 6 | GO:0061045 | |
| GeneOntologyBiologicalProcess | transepithelial transport | 6.31e-04 | 38 | 214 | 4 | GO:0070633 | |
| GeneOntologyBiologicalProcess | condensed mesenchymal cell proliferation | 6.34e-04 | 4 | 214 | 2 | GO:0072137 | |
| GeneOntologyBiologicalProcess | negative regulation of intracellular signal transduction | NLRP12 LRRK2 OBSCN NDRG2 ABCA7 ITPR1 MET ADIPOQ COMMD1 AGT NFKBIA SEMA6A DMD FBXW11 TRIM60 INPP5E RAPGEF1 SHANK2 CHEK2 | 6.53e-04 | 795 | 214 | 19 | GO:1902532 |
| GeneOntologyBiologicalProcess | microtubule-based process | MKKS IQCF1 GOLGA6B GOLGA6A LYST AK7 MET SAC3D1 DNAH5 KLC3 FBXW11 CFAP47 DNHD1 TCTE1 KIF21A SUN1 GOLGA6C GOLGA6D MEI1 CHEK2 CEP295 HYDIN HTT | 6.64e-04 | 1058 | 214 | 23 | GO:0007017 |
| GeneOntologyBiologicalProcess | microtubule-based movement | MKKS IQCF1 AK7 MET DNAH5 KLC3 FBXW11 CFAP47 DNHD1 TCTE1 KIF21A SUN1 HYDIN HTT | 6.69e-04 | 493 | 214 | 14 | GO:0007018 |
| GeneOntologyBiologicalProcess | granulocyte colony-stimulating factor signaling pathway | 6.73e-04 | 17 | 214 | 3 | GO:0038158 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid biosynthetic process | 6.97e-04 | 39 | 214 | 4 | GO:0045717 | |
| GeneOntologyBiologicalProcess | renal system development | DCHS2 LRRK2 DACT2 SULF2 ADIPOQ CLCNKA AGT TIMELESS C5 EDNRB NUP133 DCHS1 | 7.42e-04 | 386 | 214 | 12 | GO:0072001 |
| GeneOntologyBiologicalProcess | regulation of body fluid levels | CEACAM5 CEACAM6 HNF4A LYST CEACAM1 CLCNKA NBEAL2 KCNMA1 ADAMTS18 KCNN4 COL3A1 ADAMTS13 EDNRB | 7.52e-04 | 442 | 214 | 13 | GO:0050878 |
| GeneOntologyBiologicalProcess | positive regulation of glycoprotein metabolic process | 7.68e-04 | 40 | 214 | 4 | GO:1903020 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity | 7.68e-04 | 40 | 214 | 4 | GO:0045953 | |
| GeneOntologyBiologicalProcess | organelle assembly | MKKS RPS5 LRRK2 OBSCN GOLGA6B GOLGA6A TMEM80 AK7 MDN1 EIF4ENIF1 SAC3D1 DNAH5 KLC3 CFAP47 DNHD1 TBC1D15 GOLGA6C GOLGA6D RNF213 CHEK2 CEP295 HYDIN DDX28 HTT | 7.74e-04 | 1138 | 214 | 24 | GO:0070925 |
| GeneOntologyBiologicalProcess | regulation of ketone metabolic process | 8.24e-04 | 189 | 214 | 8 | GO:0010565 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immunity | 8.45e-04 | 41 | 214 | 4 | GO:0002716 | |
| GeneOntologyBiologicalProcess | fatty acid biosynthetic process | 8.82e-04 | 191 | 214 | 8 | GO:0006633 | |
| GeneOntologyBiologicalProcess | regulation of platelet aggregation | 9.26e-04 | 42 | 214 | 4 | GO:0090330 | |
| GeneOntologyBiologicalProcess | regulation of inflammatory response | NLRP12 MFHAS1 LRRK2 GBP3 TLR7 FANCA ADIPOQ AGT NFKBIA KCNN4 DAGLB AOAH EDNRB SIGLEC7 | 1.02e-03 | 515 | 214 | 14 | GO:0050727 |
| GeneOntologyCellularComponent | basal plasma membrane | EPPK1 CEACAM5 CEACAM8 CEACAM6 ABCA8 HEPH CEACAM1 MET CLCNKA KCNN4 GM2A ANK1 SLC1A5 SLC4A2 CASK | 4.01e-06 | 354 | 214 | 15 | GO:0009925 |
| GeneOntologyCellularComponent | basal part of cell | EPPK1 CEACAM5 CEACAM8 CEACAM6 ABCA8 HEPH CEACAM1 MET CLCNKA KCNN4 GM2A ANK1 SLC1A5 SLC4A2 CASK | 8.81e-06 | 378 | 214 | 15 | GO:0045178 |
| GeneOntologyCellularComponent | transforming growth factor beta ligand-receptor complex | 1.76e-05 | 16 | 214 | 4 | GO:0070021 | |
| GeneOntologyCellularComponent | basolateral plasma membrane | EPPK1 CEACAM5 CEACAM8 CEACAM6 ABCA8 HEPH CEACAM1 CLCNKA KCNN4 GM2A ANK1 SLC4A2 CASK | 2.77e-05 | 320 | 214 | 13 | GO:0016323 |
| GeneOntologyCellularComponent | apical part of cell | CEACAM5 CDHR2 CEACAM8 CEACAM6 ABCA7 CEACAM1 MGST1 CLCNKA KCNMA1 KCNN4 GM2A CNTFR CACNB3 SLC34A2 SLC4A2 SHANK2 DCHS1 | 1.34e-04 | 592 | 214 | 17 | GO:0045177 |
| GeneOntologyCellularComponent | apical plasma membrane | CEACAM5 CDHR2 CEACAM8 CEACAM6 ABCA7 CEACAM1 CLCNKA KCNMA1 KCNN4 GM2A CNTFR CACNB3 SLC34A2 SLC4A2 SHANK2 | 1.58e-04 | 487 | 214 | 15 | GO:0016324 |
| GeneOntologyCellularComponent | Golgi cis cisterna | 3.46e-04 | 33 | 214 | 4 | GO:0000137 | |
| GeneOntologyCellularComponent | Golgi stack | 3.91e-04 | 171 | 214 | 8 | GO:0005795 | |
| MousePheno | increased systemic arterial blood pressure | MKKS RAMP2 LRRK2 ADIPOQ AGT KCNMA1 KCNN4 COL3A1 CACNB3 EDNRB LRIG3 | 3.78e-06 | 158 | 171 | 11 | MP:0002842 |
| MousePheno | abnormal Golgi vesicle transport | 5.75e-06 | 22 | 171 | 5 | MP:0030949 | |
| MousePheno | abnormal metencephalon morphology | GOLGA6B GOLGA6A LYST AK7 MET GM2A HERC2 DNAH5 CLEC16A CNTFR ANK1 SUN1 GOLGA6C GOLGA6D SHANK2 HYDIN HTT | 1.56e-05 | 420 | 171 | 17 | MP:0000847 |
| MousePheno | increased alveolar macrophage number | 1.97e-05 | 14 | 171 | 4 | MP:0014228 | |
| MousePheno | abnormal cerebellum morphology | GOLGA6B GOLGA6A LYST AK7 MET GM2A HERC2 DNAH5 CLEC16A ANK1 SUN1 GOLGA6C GOLGA6D SHANK2 HYDIN HTT | 2.31e-05 | 389 | 171 | 16 | MP:0000849 |
| MousePheno | abnormal alveolar macrophage number | 2.66e-05 | 15 | 171 | 4 | MP:0014227 | |
| MousePheno | abnormal sarcolemma morphology | 2.66e-05 | 15 | 171 | 4 | MP:0004121 | |
| MousePheno | abnormal hindbrain morphology | GOLGA6B GOLGA6A LYST AK7 MET GM2A HERC2 DNAH5 CLEC16A CNTFR ANK1 INPP5E SUN1 GOLGA6C GOLGA6D SHANK2 HYDIN HTT | 2.77e-05 | 485 | 171 | 18 | MP:0000841 |
| MousePheno | abnormal systemic arterial blood pressure | MKKS RAMP2 LRRK2 ADIPOQ CLCNKB AGT KCNMA1 KCNN4 COL3A1 CACNB3 EDNRB LRIG3 | 4.82e-05 | 245 | 171 | 12 | MP:0000230 |
| MousePheno | increased skeletal muscle triglyceride level | 1.10e-04 | 21 | 171 | 4 | MP:0031415 | |
| MousePheno | decreased susceptibility to injury | DAPK1 STK11IP NDRG2 NBEAL2 KCNN4 C5 SLC34A2 RNF213 EDNRB POSTN | 1.37e-04 | 194 | 171 | 10 | MP:0005166 |
| MousePheno | abnormal sarcoplasmic reticulum morphology | 1.60e-04 | 23 | 171 | 4 | MP:0004088 | |
| MousePheno | abnormal type II pneumocyte morphology | 1.65e-04 | 67 | 171 | 6 | MP:0002275 | |
| MousePheno | premature death | GOLGA6B TLR7 GOLGA6A NDRG2 AK7 ITPR1 JAK3 MET SULF2 CLCNKB NFKBIA KCNMA1 CLEC16A VCPIP1 COL3A1 CACNB4 ANK1 GOLGA6C GOLGA6D LAMA2 ID4 ADAMTS13 EDNRB SLC4A2 CASK HYDIN HTT | 1.83e-04 | 1051 | 171 | 27 | MP:0002083 |
| MousePheno | decreased fatty acid oxidation | 1.90e-04 | 24 | 171 | 4 | MP:0014172 | |
| MousePheno | abnormal proacrosomal vesicle fusion | 1.90e-04 | 24 | 171 | 4 | MP:0031355 | |
| MousePheno | abnormal Purkinje cell morphology | GOLGA6B GOLGA6A LYST GM2A HERC2 CLEC16A ANK1 SUN1 GOLGA6C GOLGA6D | 2.06e-04 | 204 | 171 | 10 | MP:0000877 |
| MousePheno | abnormal alveolar macrophage morphology | 3.05e-04 | 27 | 171 | 4 | MP:0008245 | |
| MousePheno | increased abdominal fat pad weight | 3.05e-04 | 27 | 171 | 4 | MP:0009286 | |
| MousePheno | abnormal cerebellar cortex morphology | GOLGA6B GOLGA6A LYST MET GM2A HERC2 CLEC16A ANK1 SUN1 GOLGA6C GOLGA6D SHANK2 | 3.23e-04 | 300 | 171 | 12 | MP:0004097 |
| MousePheno | absent sperm mitochondrial sheath | 3.52e-04 | 28 | 171 | 4 | MP:0009833 | |
| MousePheno | abnormal pulmonary alveolus epithelial cell morphology | 3.55e-04 | 77 | 171 | 6 | MP:0002273 | |
| MousePheno | abnormal cerebellar Purkinje cell layer | GOLGA6B GOLGA6A LYST GM2A HERC2 CLEC16A ANK1 SUN1 GOLGA6C GOLGA6D | 3.78e-04 | 220 | 171 | 10 | MP:0000875 |
| MousePheno | pulmonary fibrosis | 3.85e-04 | 51 | 171 | 5 | MP:0006050 | |
| MousePheno | abnormal cerebellar layer morphology | GOLGA6B GOLGA6A LYST GM2A HERC2 CLEC16A ANK1 SUN1 GOLGA6C GOLGA6D SHANK2 | 3.94e-04 | 263 | 171 | 11 | MP:0009956 |
| MousePheno | abnormal motor coordination/balance | LRRK2 GOLGA6B GOLGA6A LYST ITPR1 MET PHKB KCNMA1 GM2A HERC2 DMD CACNB4 ANK1 SUN1 POLR1C GOLGA6C GOLGA6D LAMA2 SLC4A2 POSTN SHANK2 HYDIN HTT | 4.05e-04 | 873 | 171 | 23 | MP:0001516 |
| MousePheno | ataxia | GOLGA6B GOLGA6A ITPR1 KCNMA1 CACNB4 SUN1 GOLGA6C GOLGA6D LAMA2 SLC4A2 HYDIN | 4.34e-04 | 266 | 171 | 11 | MP:0001393 |
| MousePheno | abnormal pulmonary alveolus epithelium morphology | 4.36e-04 | 80 | 171 | 6 | MP:0010898 | |
| MousePheno | increased keratinocyte migration | 4.43e-04 | 3 | 171 | 2 | MP:0012193 | |
| MousePheno | abnormal response to injury | EPPK1 CEACAM5 DACT2 OBSCN CEACAM6 DAPK1 STK11IP NDRG2 CEACAM1 ADPRS ADIPOQ NBEAL2 KCNN4 C5 SLC34A2 RNF213 EDNRB POSTN | 4.61e-04 | 607 | 171 | 18 | MP:0005164 |
| MousePheno | male infertility | MKKS NUP210L GOLGA6B GOLGA6A AK7 COPS7A DHH MOV10L1 HERC2 DMD DNHD1 TCTE1 CACNB4 IQCH SUN1 GOLGA6C GOLGA6D MEI1 SLC4A2 LRIG3 PPP2R1B MAEL CEP295 HYDIN | 5.03e-04 | 944 | 171 | 24 | MP:0001925 |
| MousePheno | abnormal fatty acid oxidation | 5.03e-04 | 54 | 171 | 5 | MP:0010953 | |
| MousePheno | myopathy | 5.03e-04 | 54 | 171 | 5 | MP:0000751 | |
| MousePheno | abnormal skeletal muscle triglyceride level | 5.26e-04 | 31 | 171 | 4 | MP:0031413 | |
| MousePheno | decreased carbon dioxide production | 5.26e-04 | 31 | 171 | 4 | MP:0008964 | |
| MousePheno | decreased susceptibility to induced hypothermia | 5.93e-04 | 14 | 171 | 3 | MP:0020523 | |
| MousePheno | absent acrosome | 5.95e-04 | 32 | 171 | 4 | MP:0008839 | |
| Domain | P-loop_NTPase | NLRP12 MFHAS1 LRRK2 PEX6 GBP3 DAPK1 ABCA7 ABCA8 AK7 RAB28 MDN1 RECQL5 MOV10L1 NLRC5 MYO18B DNAH5 DNHD1 CACNB3 CACNB4 NSF KIF21A RNF213 GTPBP1 SMC2 CASK N4BP2 HYDIN DDX28 | 3.54e-07 | 848 | 211 | 28 | IPR027417 |
| Domain | - | NLRP12 MFHAS1 LRRK2 PEX6 GBP3 ABCA7 ABCA8 AK7 RAB28 MDN1 RECQL5 MOV10L1 NLRC5 DNAH5 DNHD1 CACNB3 CACNB4 NSF RNF213 GTPBP1 SMC2 CASK N4BP2 HYDIN DDX28 | 1.22e-06 | 746 | 211 | 25 | 3.40.50.300 |
| Domain | ROC_dom | 5.64e-06 | 4 | 211 | 3 | IPR020859 | |
| Domain | ROC | 5.64e-06 | 4 | 211 | 3 | PS51424 | |
| Domain | ARM-type_fold | HGH1 LRRK2 ARMH1 LYST ITPR1 NBEAL2 NCAPD2 UNC79 TTI2 MEI1 PPP2R1B MROH1 SERAC1 HTT SYMPK | 7.62e-06 | 339 | 211 | 15 | IPR016024 |
| Domain | GOLGA2L5 | 4.28e-05 | 18 | 211 | 4 | PF15070 | |
| Domain | Golgin_A | 4.28e-05 | 18 | 211 | 4 | IPR024858 | |
| Domain | ARM-like | HGH1 LRRK2 ARMH1 NBEAL2 NCAPD2 TTI2 MEI1 PPP2R1B MROH1 SERAC1 HTT SYMPK | 6.05e-05 | 270 | 211 | 12 | IPR011989 |
| Domain | Cl_channel-K | 1.27e-04 | 2 | 211 | 2 | IPR002250 | |
| Domain | HEAT | 2.02e-04 | 48 | 211 | 5 | PF02985 | |
| Domain | Ig_I-set | CEACAM5 OBSCN CEACAM8 CEACAM6 CEACAM1 HMCN2 LRIT2 LRIG3 SIGLEC7 | 3.18e-04 | 190 | 211 | 9 | IPR013098 |
| Domain | I-set | CEACAM5 OBSCN CEACAM8 CEACAM6 CEACAM1 HMCN2 LRIT2 LRIG3 SIGLEC7 | 3.18e-04 | 190 | 211 | 9 | PF07679 |
| Domain | IGc2 | CEACAM5 OBSCN CEACAM8 CEACAM6 CEACAM1 HMCN2 CNTFR LRIT2 LRIG3 SIGLEC7 | 3.52e-04 | 235 | 211 | 10 | SM00408 |
| Domain | Ig_sub2 | CEACAM5 OBSCN CEACAM8 CEACAM6 CEACAM1 HMCN2 CNTFR LRIT2 LRIG3 SIGLEC7 | 3.52e-04 | 235 | 211 | 10 | IPR003598 |
| Domain | LRR | 4.80e-04 | 201 | 211 | 9 | PS51450 | |
| Domain | HEAT | 4.94e-04 | 58 | 211 | 5 | IPR000357 | |
| Domain | VDCC_L_bsu | 7.51e-04 | 4 | 211 | 2 | IPR000584 | |
| Domain | FAS1 | 7.51e-04 | 4 | 211 | 2 | SM00554 | |
| Domain | FAS1_domain | 7.51e-04 | 4 | 211 | 2 | IPR000782 | |
| Domain | Mib_Herc2 | 7.51e-04 | 4 | 211 | 2 | IPR010606 | |
| Domain | MIB_HERC2 | 7.51e-04 | 4 | 211 | 2 | PS51416 | |
| Domain | MIB_HERC2 | 7.51e-04 | 4 | 211 | 2 | PF06701 | |
| Domain | VGCC_beta4Aa_N | 7.51e-04 | 4 | 211 | 2 | PF12052 | |
| Domain | - | 7.51e-04 | 4 | 211 | 2 | 2.30.180.10 | |
| Domain | FAS1 | 7.51e-04 | 4 | 211 | 2 | PS50213 | |
| Domain | Fasciclin | 7.51e-04 | 4 | 211 | 2 | PF02469 | |
| Domain | - | 9.76e-04 | 222 | 211 | 9 | 1.25.10.10 | |
| Domain | ZF_ZZ_2 | 1.02e-03 | 18 | 211 | 3 | PS50135 | |
| Domain | ZF_ZZ_1 | 1.02e-03 | 18 | 211 | 3 | PS01357 | |
| Domain | ZZ | 1.02e-03 | 18 | 211 | 3 | PF00569 | |
| Domain | Leu-rich_rpt | LRRC3C NLRP12 MFHAS1 LRRK2 TLR7 STK11IP NLRC5 TCTE1 LRIT2 LRIG3 | 1.06e-03 | 271 | 211 | 10 | IPR001611 |
| Domain | Znf_ZZ | 1.21e-03 | 19 | 211 | 3 | IPR000433 | |
| Domain | ZnF_ZZ | 1.21e-03 | 19 | 211 | 3 | SM00291 | |
| Domain | COUP_TF | 1.24e-03 | 5 | 211 | 2 | IPR003068 | |
| Domain | AAA | 1.27e-03 | 144 | 211 | 7 | SM00382 | |
| Domain | AAA+_ATPase | 1.27e-03 | 144 | 211 | 7 | IPR003593 | |
| Pathway | REACTOME_FIBRONECTIN_MATRIX_FORMATION | 2.70e-05 | 6 | 158 | 3 | M26970 | |
| Pathway | REACTOME_COPII_MEDIATED_VESICLE_TRANSPORT | 3.96e-05 | 83 | 158 | 7 | MM14819 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | NR2F6 EPPK1 PCNX3 MFHAS1 OBSCN PEX6 STK11IP LYST ABCA7 FANCA JAK3 FASN MDN1 EIF4ENIF1 SH3TC1 NBEAL2 NCAPD2 NLRC5 SAC3D1 HERC2 PREX1 INPP5E RAPGEF1 MIB2 SLC1A5 SHANK2 MROH1 KANK3 HTT SYMPK | 1.72e-11 | 1105 | 218 | 30 | 35748872 |
| Pubmed | Helicobacter pylori adhesin HopQ engages in a virulence-enhancing interaction with human CEACAMs. | 1.50e-09 | 4 | 218 | 4 | 27748768 | |
| Pubmed | Helicobacter pylori exploits human CEACAMs via HopQ for adherence and translocation of CagA. | 1.50e-09 | 4 | 218 | 4 | 27748756 | |
| Pubmed | 1.50e-09 | 4 | 218 | 4 | 26483485 | ||
| Pubmed | Interdependency of CEACAM-1, -3, -6, and -8 induced human neutrophil adhesion to endothelial cells. | 1.50e-09 | 4 | 218 | 4 | 19077207 | |
| Pubmed | Maximizing the ovarian reserve in mice by evading LINE-1 genotoxicity. | 1.33e-07 | 20 | 218 | 5 | 31949138 | |
| Pubmed | 2.43e-07 | 3 | 218 | 3 | 34847408 | ||
| Pubmed | 2.43e-07 | 3 | 218 | 3 | 17167768 | ||
| Pubmed | 2.43e-07 | 3 | 218 | 3 | 25409014 | ||
| Pubmed | 2.43e-07 | 3 | 218 | 3 | 22064717 | ||
| Pubmed | 2.43e-07 | 3 | 218 | 3 | 31171910 | ||
| Pubmed | 9.67e-07 | 4 | 218 | 3 | 10436421 | ||
| Pubmed | Globozoospermia and lack of acrosome formation in GM130-deficient mice. | 1.03e-06 | 13 | 218 | 4 | 28055014 | |
| Pubmed | GM130 regulates pulmonary surfactant protein secretion in alveolar type II cells. | 1.03e-06 | 13 | 218 | 4 | 33740186 | |
| Pubmed | Loss of the golgin GM130 causes Golgi disruption, Purkinje neuron loss, and ataxia in mice. | 1.03e-06 | 13 | 218 | 4 | 28028212 | |
| Pubmed | GOLGA2 loss causes fibrosis with autophagy in the mouse lung and liver. | 1.03e-06 | 13 | 218 | 4 | 29128360 | |
| Pubmed | Loss of GM130 does not impair oocyte meiosis and embryo development in mice. | 1.03e-06 | 13 | 218 | 4 | 32873390 | |
| Pubmed | 1.03e-06 | 13 | 218 | 4 | 21552007 | ||
| Pubmed | 1.43e-06 | 14 | 218 | 4 | 29907459 | ||
| Pubmed | 1.43e-06 | 14 | 218 | 4 | 28567513 | ||
| Pubmed | 1.43e-06 | 14 | 218 | 4 | 8207827 | ||
| Pubmed | Golgb1 regulates protein glycosylation and is crucial for mammalian palate development. | 1.43e-06 | 14 | 218 | 4 | 27226319 | |
| Pubmed | 1.43e-06 | 14 | 218 | 4 | 37831422 | ||
| Pubmed | 1.43e-06 | 14 | 218 | 4 | 11994468 | ||
| Pubmed | 1.43e-06 | 14 | 218 | 4 | 20381490 | ||
| Pubmed | 1.43e-06 | 14 | 218 | 4 | 22159884 | ||
| Pubmed | 1.43e-06 | 14 | 218 | 4 | 30630895 | ||
| Pubmed | CEACAM2 positively regulates integrin αIIbβ3-mediated platelet functions. | 1.43e-06 | 14 | 218 | 4 | 27161904 | |
| Pubmed | 1.43e-06 | 14 | 218 | 4 | 23070997 | ||
| Pubmed | 1.43e-06 | 14 | 218 | 4 | 10491101 | ||
| Pubmed | Oligoasthenoteratospermia and sperm tail bending in PPP4C-deficient mice. | 1.43e-06 | 14 | 218 | 4 | 33543287 | |
| Pubmed | Golgi disruption and early embryonic lethality in mice lacking USO1. | 1.94e-06 | 15 | 218 | 4 | 23185636 | |
| Pubmed | Mouse oocytes within germ cell cysts and primordial follicles contain a Balbiani body. | 1.94e-06 | 15 | 218 | 4 | 17189423 | |
| Pubmed | 1.94e-06 | 15 | 218 | 4 | 24948196 | ||
| Pubmed | GM130 Regulates Golgi-Derived Spindle Assembly by Activating TPX2 and Capturing Microtubules. | 1.94e-06 | 15 | 218 | 4 | 26165940 | |
| Pubmed | 1.94e-06 | 15 | 218 | 4 | 20410265 | ||
| Pubmed | 1.94e-06 | 15 | 218 | 4 | 26586918 | ||
| Pubmed | 1.94e-06 | 15 | 218 | 4 | 25490771 | ||
| Pubmed | Insulin acutely decreases hepatic fatty acid synthase activity. | 1.94e-06 | 15 | 218 | 4 | 16054098 | |
| Pubmed | The a3 isoform of V-ATPase regulates insulin secretion from pancreatic beta-cells. | 1.94e-06 | 15 | 218 | 4 | 17046993 | |
| Pubmed | 1.94e-06 | 15 | 218 | 4 | 37635409 | ||
| Pubmed | Golga5 is dispensable for mouse embryonic development and postnatal survival. | 1.94e-06 | 15 | 218 | 4 | 28509431 | |
| Pubmed | Calumin, a novel Ca2+-binding transmembrane protein on the endoplasmic reticulum. | 1.94e-06 | 15 | 218 | 4 | 17204322 | |
| Pubmed | 1.94e-06 | 15 | 218 | 4 | 16413118 | ||
| Pubmed | 1.94e-06 | 15 | 218 | 4 | 26083584 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | NR2F6 WDR55 NUP205 FASN MDN1 SH3TC1 GLYR1 NFKBIA NCAPD2 VARS1 FBXW11 NSF CHAF1A HMGXB4 ID4 SMC2 CHEK2 NUP133 SYMPK | 2.28e-06 | 857 | 218 | 19 | 25609649 |
| Pubmed | 2.58e-06 | 16 | 218 | 4 | 16399995 | ||
| Pubmed | 2.58e-06 | 16 | 218 | 4 | 25085348 | ||
| Pubmed | 2.58e-06 | 16 | 218 | 4 | 11784862 | ||
| Pubmed | 2.58e-06 | 16 | 218 | 4 | 16336229 | ||
| Pubmed | Differences in tissue-specific and embryonic expression of mouse Ceacam1 and Ceacam2 genes. | 2.58e-06 | 16 | 218 | 4 | 11284729 | |
| Pubmed | 2.58e-06 | 16 | 218 | 4 | 18166528 | ||
| Pubmed | p125/Sec23-interacting protein (Sec23ip) is required for spermiogenesis. | 2.58e-06 | 16 | 218 | 4 | 21640725 | |
| Pubmed | 3.35e-06 | 17 | 218 | 4 | 27655914 | ||
| Pubmed | 3.35e-06 | 17 | 218 | 4 | 14728599 | ||
| Pubmed | 3.35e-06 | 17 | 218 | 4 | 28717168 | ||
| Pubmed | Phospholipase D2 localizes to the plasma membrane and regulates angiotensin II receptor endocytosis. | 3.35e-06 | 17 | 218 | 4 | 14718562 | |
| Pubmed | 3.35e-06 | 17 | 218 | 4 | 20004763 | ||
| Pubmed | 4.29e-06 | 18 | 218 | 4 | 15800058 | ||
| Pubmed | Altered GLUT4 trafficking in adipocytes in the absence of the GTPase Arfrp1. | 4.29e-06 | 18 | 218 | 4 | 20230794 | |
| Pubmed | 4.29e-06 | 18 | 218 | 4 | 22718342 | ||
| Pubmed | 4.29e-06 | 18 | 218 | 4 | 20943658 | ||
| Pubmed | 4.29e-06 | 18 | 218 | 4 | 25208654 | ||
| Pubmed | 4.29e-06 | 18 | 218 | 4 | 21147753 | ||
| Pubmed | 4.29e-06 | 18 | 218 | 4 | 24227724 | ||
| Pubmed | Protein kinase LKB1 regulates polarized dendrite formation of adult hippocampal newborn neurons. | 4.29e-06 | 18 | 218 | 4 | 24367100 | |
| Pubmed | Global defects in collagen secretion in a Mia3/TANGO1 knockout mouse. | 4.47e-06 | 39 | 218 | 5 | 21606205 | |
| Pubmed | Cell influx and contractile actomyosin force drive mammary bud growth and invagination. | 5.41e-06 | 19 | 218 | 4 | 34042944 | |
| Pubmed | 5.41e-06 | 19 | 218 | 4 | 15452145 | ||
| Pubmed | Deletion of IFT20 exclusively in the RPE ablates primary cilia and leads to retinal degeneration. | 5.41e-06 | 19 | 218 | 4 | 38048369 | |
| Pubmed | 5.41e-06 | 19 | 218 | 4 | 12646573 | ||
| Pubmed | 5.41e-06 | 19 | 218 | 4 | 17724343 | ||
| Pubmed | Scrg1, a novel protein of the CNS is targeted to the large dense-core vesicles in neuronal cells. | 5.41e-06 | 19 | 218 | 4 | 14622145 | |
| Pubmed | 5.41e-06 | 19 | 218 | 4 | 22841714 | ||
| Pubmed | 5.41e-06 | 19 | 218 | 4 | 23444373 | ||
| Pubmed | CLASP2 safeguards hematopoietic stem cell properties during mouse and fish development. | 5.41e-06 | 19 | 218 | 4 | 35705037 | |
| Pubmed | Divergent functions and distinct localization of the Notch ligands DLL1 and DLL3 in vivo. | 5.41e-06 | 19 | 218 | 4 | 17664336 | |
| Pubmed | Stage-dependent function of Wnt5a during male external genitalia development. | 5.41e-06 | 19 | 218 | 4 | 34255394 | |
| Pubmed | Regulation of amino acid transporter ATA2 by ubiquitin ligase Nedd4-2. | 5.41e-06 | 19 | 218 | 4 | 17003038 | |
| Pubmed | Overlapping Role of SCYL1 and SCYL3 in Maintaining Motor Neuron Viability. | 6.72e-06 | 20 | 218 | 4 | 29437892 | |
| Pubmed | 6.72e-06 | 20 | 218 | 4 | 23918928 | ||
| Pubmed | The COPI vesicle complex binds and moves with survival motor neuron within axons. | 6.72e-06 | 20 | 218 | 4 | 21300694 | |
| Pubmed | Development of the post-natal growth plate requires intraflagellar transport proteins. | 6.72e-06 | 20 | 218 | 4 | 17359961 | |
| Pubmed | The molecular complex of ciliary and golgin protein is crucial for skull development. | 6.72e-06 | 20 | 218 | 4 | 34128978 | |
| Pubmed | 6.72e-06 | 20 | 218 | 4 | 30236446 | ||
| Pubmed | Intraflagellar transport molecules in ciliary and nonciliary cells of the retina. | 6.72e-06 | 20 | 218 | 4 | 20368623 | |
| Pubmed | UBAP2 HEPH NUP205 STAB1 SULF2 AGO4 NBEAL2 NCAPD2 INPP5E KIF21A SUN1 ANKRD50 DIS3 LRIG3 | 7.25e-06 | 529 | 218 | 14 | 14621295 | |
| Pubmed | Canonical and noncanonical intraflagellar transport regulates craniofacial skeletal development. | 8.27e-06 | 21 | 218 | 4 | 27118846 | |
| Pubmed | 8.27e-06 | 21 | 218 | 4 | 23386608 | ||
| Pubmed | 8.27e-06 | 21 | 218 | 4 | 15229288 | ||
| Pubmed | Mechanism of primitive duct formation in the pancreas and submandibular glands: a role for SDF-1. | 8.27e-06 | 21 | 218 | 4 | 20003423 | |
| Pubmed | 8.27e-06 | 21 | 218 | 4 | 21645620 | ||
| Pubmed | 8.27e-06 | 21 | 218 | 4 | 36292593 | ||
| Pubmed | Rap2 function requires palmitoylation and recycling endosome localization. | 8.27e-06 | 21 | 218 | 4 | 19061864 | |
| Pubmed | Ror2 enhances polarity and directional migration of primordial germ cells. | 8.27e-06 | 21 | 218 | 4 | 22216013 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | EPPK1 FASN MDN1 NCAPD2 VARS1 CHAF1A HMGXB4 RNF213 SMC2 SRRT SYMPK | 9.03e-06 | 332 | 218 | 11 | 32786267 |
| Pubmed | Control of craniofacial development by the collagen receptor, discoidin domain receptor 2. | 1.01e-05 | 22 | 218 | 4 | 36656123 | |
| Pubmed | 1.01e-05 | 22 | 218 | 4 | 34897463 | ||
| Pubmed | UBAP2 DAPK1 GOLGA6B GOLGA6A MDN1 KCNMA1 HERC2 UNC79 CACNB4 PRR36 NSF KIF21A GOLGA6C GOLGA6D SMC2 CASK SHANK2 N4BP2 DCHS1 | 1.19e-05 | 963 | 218 | 19 | 28671696 | |
| Pubmed | 1.21e-05 | 23 | 218 | 4 | 25636444 | ||
| Interaction | TOP3B interactions | NR2F6 EPPK1 UBAP2 PCNX3 MFHAS1 OBSCN PEX6 STK11IP LYST ABCA7 FANCA JAK3 FASN MDN1 EIF4ENIF1 SH3TC1 NBEAL2 RECQL5 NCAPD2 NLRC5 SAC3D1 HERC2 PREX1 INPP5E RAPGEF1 R3HDM2 MIB2 GTPBP1 SLC1A5 IGF2BP2 SHANK2 MROH1 KANK3 DDX28 HTT SYMPK | 1.17e-06 | 1470 | 209 | 36 | int:TOP3B |
| Interaction | CEACAM1 interactions | 2.03e-06 | 21 | 209 | 5 | int:CEACAM1 | |
| Interaction | VN1R1 interactions | 4.36e-06 | 4 | 209 | 3 | int:VN1R1 | |
| Interaction | CLRN3 interactions | 7.47e-06 | 13 | 209 | 4 | int:CLRN3 | |
| Interaction | TAS2R60 interactions | 1.08e-05 | 5 | 209 | 3 | int:TAS2R60 | |
| Interaction | GPR45 interactions | PEX6 STK11IP NUP205 FANCA MDN1 NBEAL2 MMS22L TBC1D15 TTI2 RNF213 PPP2R1B MROH1 SERAC1 | 1.60e-05 | 300 | 209 | 13 | int:GPR45 |
| Interaction | GPR182 interactions | NUP205 FANCA MDN1 NBEAL2 NCAPD2 KCNN4 TIMELESS MMS22L TTI2 SUN1 RNF213 SLC4A2 MROH1 CHEK2 HTT SYMPK | 2.29e-05 | 455 | 209 | 16 | int:GPR182 |
| Interaction | NFKBIB interactions | 3.13e-05 | 86 | 209 | 7 | int:NFKBIB | |
| Cytoband | 19q13.3 | 4.67e-05 | 82 | 218 | 5 | 19q13.3 | |
| Cytoband | 17q12-q21.1 | 6.71e-05 | 3 | 218 | 2 | 17q12-q21.1 | |
| Cytoband | 8q24.3 | 2.13e-04 | 113 | 218 | 5 | 8q24.3 | |
| Cytoband | 6p21.1 | 5.90e-04 | 80 | 218 | 4 | 6p21.1 | |
| GeneFamily | CD molecules|V-set domain containing|Immunoglobulin like domain containing|Carcinoembryonic antigen related cell adhesion molecule family | 1.20e-06 | 24 | 146 | 5 | 906 | |
| GeneFamily | Ankyrin repeat domain containing | 1.57e-04 | 242 | 146 | 9 | 403 | |
| GeneFamily | Cadherin related | 3.23e-04 | 17 | 146 | 3 | 24 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 3.85e-04 | 18 | 146 | 3 | 91 | |
| GeneFamily | Potassium calcium-activated channels | 9.51e-04 | 6 | 146 | 2 | 255 | |
| GeneFamily | Calcium voltage-gated channel subunits|Membrane associated guanylate kinases | 1.17e-03 | 26 | 146 | 3 | 904 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 2.10e-03 | 163 | 146 | 6 | 590 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 2.25e-03 | 9 | 146 | 2 | 1230 | |
| GeneFamily | Chloride voltage-gated channels | 2.79e-03 | 10 | 146 | 2 | 302 | |
| Coexpression | SWEET_LUNG_CANCER_KRAS_DN | RAMP2 MFHAS1 ETS2 GBP3 NDRG2 HEPH STAB1 RAB28 ADIPOQ NFKBIA COL3A1 LAMA2 EDNRB POSTN KANK3 | 4.42e-06 | 444 | 215 | 15 | MM1051 |
| Coexpression | ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_UP | CPPED1 CEACAM3 LRRK2 GBP3 TLR7 LYST CEACAM1 STAB1 SERPINB9 ADPRS NFKBIE GM2A DSE VCPIP1 AOAH RNF213 GTPBP1 SLC1A5 PARP10 IGF2BP2 SIGLEC7 ARSD RASGEF1B | 1.08e-05 | 1012 | 215 | 23 | M40868 |
| Coexpression | SWEET_LUNG_CANCER_KRAS_DN | RAMP2 MFHAS1 ETS2 NDRG2 HEPH STAB1 RAB28 ADIPOQ NFKBIA COL3A1 LAMA2 EDNRB POSTN KANK3 | 1.14e-05 | 422 | 215 | 14 | M7396 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C2_PROMONOCYTE_LIKE_CELL | ARMH1 FANCA FASN MGST1 NCAPD2 NLRC5 SAC3D1 TIMELESS CHAF1A SMC2 IGF2BP2 | 3.01e-05 | 290 | 215 | 11 | M45736 |
| Coexpression | PEDRIOLI_MIR31_TARGETS_DN | RAMP2 MOSPD3 HSPA12B ABCA7 MDN1 VCPIP1 MTMR12 KIF21A LAMA2 MIB2 PKHD1L1 EDNRB ARSD | 4.03e-05 | 413 | 215 | 13 | M2494 |
| Coexpression | GSE41867_DAY8_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_DN | 4.33e-05 | 200 | 215 | 9 | M9484 | |
| Coexpression | GSE18893_TCONV_VS_TREG_24H_CULTURE_DN | LRRK2 ETS2 TIMELESS DMPK MMS22L RNF213 ANKRD50 N4BP2 RASGEF1B | 4.33e-05 | 200 | 215 | 9 | M7289 |
| ToppCell | facs-Heart-RA-18m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RAMP2 ETS2 HSPA12B CEACAM1 STAB1 SH3TC1 SEMA6A RAPGEF1 EDNRB USHBP1 KANK3 | 3.59e-09 | 195 | 218 | 11 | 30c75761079fa1e1a3b84d23c88a222f459d5ce5 |
| ToppCell | droplet-Heart-nan-18m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-08 | 174 | 218 | 10 | cf4e0567f2a4ebe5534046b1c091af59b55bdc4f | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.53e-08 | 183 | 218 | 10 | e972432dd4d1bd31bb0982f4df3061e5e152658f | |
| ToppCell | Control-Epithelial_alveolar-AT_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | ESRP1 DACT2 DAPK1 MGST1 C5 CACNB4 KIF21A SLC34A2 SHANK2 RORC | 2.66e-08 | 184 | 218 | 10 | 51e129b3fcc2df083eda05a3afe3717218b1e52b |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | LRRK2 ESRP1 DACT2 DAPK1 C5 CACNB4 KIF21A SLC34A2 SHANK2 RORC | 2.80e-08 | 185 | 218 | 10 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | LRRK2 ESRP1 DACT2 MGST1 C5 CACNB4 KIF21A SLC34A2 SHANK2 RORC | 2.95e-08 | 186 | 218 | 10 | e83718fabb057100835d3357df407f283d23fe16 |
| ToppCell | COVID-19-Heart-EC_(POSTN)|Heart / Disease (COVID-19 only), tissue and cell type | DAPK1 SULF2 SERPINB9 MOV10L1 FGD5 ANKRD50 PKHD1L1 POSTN LRIG3 RASGEF1B | 3.98e-08 | 192 | 218 | 10 | c0c34785a7bdf461722029b322e9184e3d9b3c26 |
| ToppCell | facs-Heart-RA-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RAMP2 ETS2 HSPA12B CEACAM1 STAB1 FGD5 SEMA6A EDNRB USHBP1 KANK3 | 4.61e-08 | 195 | 218 | 10 | f4fdcc0b851392086e9618e76ee6a0b540d5fb3c |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | RAMP2 ETS2 HSPA12B CEACAM1 STAB1 FGD5 SEMA6A COL3A1 KANK3 DCHS1 | 5.32e-08 | 198 | 218 | 10 | 259fbcc0f2ac281a3e4d693de45b986fe5e24841 |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | RAMP2 ETS2 HSPA12B CEACAM1 STAB1 FGD5 SEMA6A USHBP1 KANK3 DCHS1 | 5.58e-08 | 199 | 218 | 10 | 8b62d43af8b2ebb4c1b2d068d50beaf35728dbe7 |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | RAMP2 ETS2 HSPA12B CEACAM1 STAB1 FGD5 SEMA6A USHBP1 KANK3 DCHS1 | 5.58e-08 | 199 | 218 | 10 | da5a88749d859d535daa030d0974485906cc0ba7 |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | RAMP2 ETS2 HSPA12B CEACAM1 STAB1 FGD5 COL3A1 USHBP1 KANK3 DCHS1 | 5.58e-08 | 199 | 218 | 10 | f35e9c05d0a0339ff691b38564da7aad8e9218aa |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.46e-08 | 159 | 218 | 9 | d3f81ba22160568ccaa6d2b04ebfd30630f9a6db | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-07 | 172 | 218 | 9 | c056d44e2e130ceccadfcdceb192a7f095d779c8 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.59e-07 | 179 | 218 | 9 | fd2cbee532e7b44113410dca82aec7db1a7fb69f | |
| ToppCell | Control-Epithelial_alveolar-AT_1-AT1-AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.99e-07 | 182 | 218 | 9 | a95956ce4adccb34cc0c47ebfa1878ce4617904e | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.99e-07 | 182 | 218 | 9 | 1e2149b222a3e9f64841aed45288a6f29394e7b0 | |
| ToppCell | Control-Epithelial_alveolar-AT_2-AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.99e-07 | 182 | 218 | 9 | e97681a4102f3095d5d9e90ad70f1dc46e90983a | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.11e-07 | 133 | 218 | 8 | 5bf5e654653e2c340891f51e3f2a30441b7b6b2b | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT1-AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.13e-07 | 183 | 218 | 9 | 06ac66726ec53db810ebb90ec69cfdb903da53f6 | |
| ToppCell | droplet-Trachea-3m-Endothelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.27e-07 | 184 | 218 | 9 | ad520ab6bb776b5303df505b7e1afb22484f18a7 | |
| ToppCell | droplet-Trachea-nan-3m-Endothelial-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.27e-07 | 184 | 218 | 9 | 1d63cb75a89c5f3f3b9ebf7fce8cb0fd4a92b645 | |
| ToppCell | droplet-Trachea-nan-3m-Endothelial-endothelial_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.27e-07 | 184 | 218 | 9 | 76caad53d55fff5acca27bf190a6de7b27437d9f | |
| ToppCell | droplet-Trachea-3m-Endothelial-endothelial_cell_of_trachea|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.27e-07 | 184 | 218 | 9 | 1fc1f0a3b4dbb085ebcc3960f67be24a108fe5b9 | |
| ToppCell | droplet-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.27e-07 | 184 | 218 | 9 | 2467207aaea307873ab286f89cfc7668a227a694 | |
| ToppCell | droplet-Trachea-nan-3m-Endothelial|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.27e-07 | 184 | 218 | 9 | fa5c3020e75fdde1363393dea97ebd99f1eae9ff | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.27e-07 | 184 | 218 | 9 | ab2f06906fc7a9931dfa0864ef506832b07fb93e | |
| ToppCell | Control-Epithelial_alveolar-AT_2-AT2_Progenitor|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.43e-07 | 185 | 218 | 9 | 8ca1374501eca01d8468130b74d50abfd4329fbe | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.59e-07 | 186 | 218 | 9 | 2ea5ff14861e5f91d0e6a5767c403a24045d715c | |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.59e-07 | 186 | 218 | 9 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 3.92e-07 | 188 | 218 | 9 | c90669b51e1902fe7726555290c91c92a911df83 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.92e-07 | 188 | 218 | 9 | 43a0508d2524a5b310e89e9422843dcaab999bc3 | |
| ToppCell | Adult|World / Lineage, Cell type, age group and donor | CEACAM6 FASN MGST1 KCNMA1 DNAH5 SLC34A2 RAPGEF1 RNF213 MROH1 | 4.10e-07 | 189 | 218 | 9 | 5cd285bfad973125d46d704fec18b21266a63379 |
| ToppCell | droplet-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l10|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.10e-07 | 189 | 218 | 9 | 28b9e96a5206b7fdae9b17daf05c8f5d24b6c5ec | |
| ToppCell | EC-Sinusoidal_ECs|World / Lineage and Cell class | 4.10e-07 | 189 | 218 | 9 | 9a0956c8a7069ba3bd0fa56d052d6e514453e578 | |
| ToppCell | Adult-Immune-monocyte-D175|Adult / Lineage, Cell type, age group and donor | 4.48e-07 | 191 | 218 | 9 | cbebb4d9550fdcd606cb3685ac9546c6b73fd422 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.68e-07 | 192 | 218 | 9 | 9d53b42cdb537b30233cdfdc08052c8b13a1113f | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.68e-07 | 192 | 218 | 9 | 042391162df2e3d0027688dd14163c4c6821afe0 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.68e-07 | 192 | 218 | 9 | 71b0bfee0461ff64cef35881db3959c517e9731b | |
| ToppCell | facs-Heart-RA-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.89e-07 | 193 | 218 | 9 | e7805e866339f676e3f770980c2e0a649eff472e | |
| ToppCell | (4)_Endothelial_cells|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 4.89e-07 | 193 | 218 | 9 | ae6ba13d4d9f2a700887cdda2790c32007b29ac8 | |
| ToppCell | facs-Heart-RA-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.89e-07 | 193 | 218 | 9 | 1ad941098f1a44a46c2f6ebff32a98ada32c80ab | |
| ToppCell | droplet-Lung-3m-Mesenchymal-myofibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.11e-07 | 194 | 218 | 9 | c992e3357f4bf3069f8d697803e5785e49a2ef0a | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.33e-07 | 195 | 218 | 9 | 12ba6d95e42d06b1991b011043c0e3370a7b4131 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.57e-07 | 196 | 218 | 9 | 95c5b8fd4ebfae1f42de9b1475c1161d4a80e515 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.81e-07 | 197 | 218 | 9 | 1485933986921ff45669d9b7501c8d17050b3e97 | |
| ToppCell | ASK452-Epithelial-Transformed_epithelium|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 5.81e-07 | 197 | 218 | 9 | b22a79a5922c865a360e2afc5506a08a512fa76a | |
| ToppCell | mild-HLA-DR-_S100A+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.32e-07 | 199 | 218 | 9 | d0d286eafe935f9b3aaba5b783e8911251121b4a | |
| ToppCell | PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.32e-07 | 199 | 218 | 9 | dbf0bf09896c46155ae6fbd6307f097799e7e34e | |
| ToppCell | PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.32e-07 | 199 | 218 | 9 | 9314eb9a89407738626a0384884454b5f9031ee7 | |
| ToppCell | Kidney-Endothelial|Kidney / Skin and Kidney Cells in Lupus Nephritis Patients. | 6.32e-07 | 199 | 218 | 9 | b543f0686522df43737e9ffa5c9733e42b8a9f4d | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.59e-07 | 200 | 218 | 9 | 89821a264e872ed53e08e9d3609d5cc5c314503e | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.59e-07 | 200 | 218 | 9 | 2e47888e041ec3d265425d1df97b6665c6da889c | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | ESRP1 DAPK1 CEACAM1 KCNMA1 KCNN4 CACNB4 IGF2BP2 SHANK2 DACH2 | 6.59e-07 | 200 | 218 | 9 | 0eb9ad8c0373bcc62029ec21c590ed03aaacd039 |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.59e-07 | 200 | 218 | 9 | 50fa0f8a3e490d5941b34e66a10158eba6c909d4 | |
| ToppCell | lung-Type_II_Pneumocytes|lung / shred on tissue and cell subclass | 6.68e-07 | 147 | 218 | 8 | 8a3039de45b8087f8319e2e37329acf7278219b7 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-06 | 157 | 218 | 8 | b527e88382c8d21188a0f222b3302523e8816dfc | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2-Slc17a8.Synpr-Sncg-Yjefn3_(Neuron.Gad1Gad2-Slc17a8.Synpr-Sncg-Yjefn3)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.12e-06 | 69 | 218 | 6 | 0862e6c8d8af4310b9a1f0879e51ee25115b26b1 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2-Slc17a8.Synpr-Sncg-Yjefn3_(Neuron.Gad1Gad2-Slc17a8.Synpr-Sncg-Yjefn3)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.12e-06 | 69 | 218 | 6 | d2ff9cea216122d697822cdd2eecbce8f557728d | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.67e-06 | 166 | 218 | 8 | bb8135119dc37fdbba476599a56d368f422688dc | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.67e-06 | 166 | 218 | 8 | c20479fe7a4306320d7f26e78bf956225f00f35a | |
| ToppCell | droplet-Marrow-nan-24m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-06 | 168 | 218 | 8 | e979a4fbeb9f21048b47d69e6da75c57650697f2 | |
| ToppCell | droplet-Heart-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-06 | 169 | 218 | 8 | 2e5bb6437bc9c614e337c5ffb6f6457cd9fc7f4c | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.09e-06 | 171 | 218 | 8 | 09e653973962fb884878089d281f0947f7a285f6 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.09e-06 | 171 | 218 | 8 | 82de2885c8ce4fb7776da6a0207b3355c0910121 | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-06 | 173 | 218 | 8 | c31076c725f4cd912c56903592a2d9356ae59f54 | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-06 | 173 | 218 | 8 | a4ed191cfdf6588b7f3672995bf0a4fe9e4b8df6 | |
| ToppCell | droplet-Lung-21m-Epithelial-airway_epithelial-lung_ciliated_cell-ciliated_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.70e-06 | 177 | 218 | 8 | d5640f0097878f0dac671e51dc51310278bb2682 | |
| ToppCell | droplet-Lung-21m-Epithelial-airway_epithelial-lung_ciliated_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.70e-06 | 177 | 218 | 8 | d947ba38db1772fc5fdcdc211f7511c4aa699dee | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.05e-06 | 180 | 218 | 8 | b798a3fa2dd15b68aa4267f665559527043dcc07 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.11e-06 | 127 | 218 | 7 | 5b0adbcafad31a6759c9bdce2f7f9591a8edc450 | |
| ToppCell | LPS-IL1RA-Endothelial-Epi-like-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.11e-06 | 127 | 218 | 7 | 6b24630978eb0772b4cd3bf59e5bc4390be47619 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-AT2_Progenitor|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.18e-06 | 181 | 218 | 8 | 0513b9e6673ff7bf8e72ba123ca3794b65d10170 | |
| ToppCell | PBMC-Convalescent-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.18e-06 | 181 | 218 | 8 | 2b9b460239d67fd480cee60820cdb306109d3567 | |
| ToppCell | PBMC-Convalescent-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.18e-06 | 181 | 218 | 8 | 2a1aa4a0ec7bc367857beaff543135e4345c835b | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 3.18e-06 | 181 | 218 | 8 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.32e-06 | 182 | 218 | 8 | d1a1feef318062f25493355d7beee8e5fb0e4206 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.32e-06 | 182 | 218 | 8 | 17ed11a7ea366dd3106400511d5e628d3f1a9c3e | |
| ToppCell | facs-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l54|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.32e-06 | 182 | 218 | 8 | d22ab50b135482915687c70e6dad29bfe2bb2c68 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.59e-06 | 184 | 218 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.59e-06 | 184 | 218 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-AT2_Progenitor|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.59e-06 | 184 | 218 | 8 | d0c212a8fbaad24597a84018442b25c61c17ea58 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.59e-06 | 184 | 218 | 8 | 7cc5796557379c3d1db078c1aeda40659c6e401c | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.59e-06 | 184 | 218 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.74e-06 | 185 | 218 | 8 | fefaf227d89f680d6f3e91c4a94e26ab4d0dc6c3 | |
| ToppCell | Control-Epithelial_alveolar|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.74e-06 | 185 | 218 | 8 | 3937e026add96a396122139daf8011cfbc60e75c | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-AT1-AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.74e-06 | 185 | 218 | 8 | 68f428e169cfb77de970bdfdeea9b9f16f68d2ba | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-Tuft-related|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.89e-06 | 186 | 218 | 8 | 4046b701aa29712d9f7c774f8955215122c3c003 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.89e-06 | 186 | 218 | 8 | ac7a84b11b4550c4ac01eab370dc8ab88e4fb72b | |
| ToppCell | LPS_only-Epithelial_alveolar|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.89e-06 | 186 | 218 | 8 | e0a2ea4b46af742bc7c9b2072bb85e27d5c92712 | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-Tuft-related-BEST4+_epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.89e-06 | 186 | 218 | 8 | bd5837033c1ffcbe5dd30195cc4846a2ba351bcd | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|World / Lineage, Cell type, age group and donor | 4.05e-06 | 187 | 218 | 8 | 81cc8435b2704a9a8287b3f54acaae0f11dd4ac7 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.05e-06 | 187 | 218 | 8 | 2b1b2c3792d6c9ab69675ce88842bb589414b530 | |
| ToppCell | facs-Aorta-Heart-3m-Endothelial-nan|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.05e-06 | 187 | 218 | 8 | df0279b7e94e26f5541b0e2a0ce56befa96ec8ca | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.05e-06 | 187 | 218 | 8 | f3397dbc23b6c2f24e2c1ba887d8f9aef3ee01a1 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.05e-06 | 187 | 218 | 8 | 401be371b32066db926de3415bb4ce9465749dc3 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.05e-06 | 187 | 218 | 8 | f124d2c699b717b7c02a1a70493f515b83dc2f4c | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.21e-06 | 188 | 218 | 8 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.21e-06 | 188 | 218 | 8 | 6164d467b612767ceba15de34176bcc8e8c36ab8 | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 4.21e-06 | 188 | 218 | 8 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| Computational | Genes in the cancer module 397. | 9.48e-05 | 121 | 128 | 8 | MODULE_397 | |
| Drug | vinblastine sulfate; Down 200; 0.1uM; PC3; HT_HG-U133A | CDHR2 TMEM80 LYST ITPR1 MET GLYR1 FBXW11 REX1BD CACNB3 SUN1 SRRT TRAPPC10 | 3.68e-07 | 198 | 212 | 12 | 7556_DN |
| Drug | Proadifen hydrochloride [62-68-0]; Up 200; 10.2uM; MCF7; HT_HG-U133A | EPOR CPPED1 WDR55 TMEM80 ABCA7 STAB1 NFKBIA GM2A DMPK SLC1A4 EDNRB | 2.08e-06 | 193 | 212 | 11 | 3446_UP |
| Drug | Mevalonic-D, L acid lactone [674-26-0]; Up 200; 30.8uM; MCF7; HT_HG-U133A | EPOR CDHR2 TMEM80 NDRG2 ABCA7 CEACAM1 ITPR1 RECQL5 SLC1A4 PPP2R1B SHANK2 | 2.54e-06 | 197 | 212 | 11 | 3459_UP |
| Drug | (-)-depudecin; Up 200; 1uM; MCF7; HT_HG-U133A_EA | EPOR NR2F6 NDRG2 MET RAB28 SERPINB9 KCNN4 CLEC16A VCPIP1 PRR36 | 1.41e-05 | 193 | 212 | 10 | 982_UP |
| Drug | Cyclobenzaprine hydrochloride [6202-23-9]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 1.54e-05 | 195 | 212 | 10 | 3268_UP | |
| Drug | daunorubicin HCl; Up 200; 1uM; PC3; HT_HG-U133A | EPOR CPPED1 NFKBIA NFKBIE DMPK VCPIP1 REX1BD MTMR12 PPP2R1B PTCH2 | 1.61e-05 | 196 | 212 | 10 | 7511_UP |
| Drug | Furaltadone hydrochloride [3759-92-0]; Down 200; 11uM; MCF7; HT_HG-U133A | NR2F6 CEACAM6 MET GLYR1 GM2A TIMELESS CLEC16A CHAF1A SLC1A4 SRRT | 1.68e-05 | 197 | 212 | 10 | 3838_DN |
| Drug | Dicloxacillin sodium salt [13412-64-1]; Up 200; 8.2uM; PC3; HT_HG-U133A | CEACAM3 WDR55 CEACAM1 AGT RECQL5 KCNMA1 SEMA6A DMPK SLC34A2 TEF | 1.68e-05 | 197 | 212 | 10 | 6666_UP |
| Drug | Lithocholic acid [434-13-9]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 1.68e-05 | 197 | 212 | 10 | 3899_UP | |
| Drug | Sulfaquinoxaline sodium salt [967-80-6]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 1.76e-05 | 198 | 212 | 10 | 6788_UP | |
| Drug | Troleandomycin [2751-09-9]; Up 200; 5uM; MCF7; HT_HG-U133A | STAB1 FANCA SH3TC1 KCNMA1 GM2A DMPK SLC1A4 EDNRB SIGLEC7 SYMPK | 1.76e-05 | 198 | 212 | 10 | 1465_UP |
| Drug | Methamphetamine | EPOR RAMP2 PCNX3 CDHR2 NUP210L IQCF1 OBSCN PEX6 HSPA12B STK11IP JAK3 SERPINB9 ADIPOQ CLCNKB NFKBIA GM2A HERC2 DMD MYO18B DMPK CNTFR COL3A1 CACNB4 AOAH TEF DIS3 SRRT LRIG3 KANK3 | 4.53e-05 | 1401 | 212 | 29 | ctd:D008694 |
| Drug | AC1L1IPV | 4.82e-05 | 43 | 212 | 5 | CID000004683 | |
| Drug | Etoposide [33419-42-0]; Up 200; 6.8uM; MCF7; HT_HG-U133A | 5.70e-05 | 183 | 212 | 9 | 5027_UP | |
| Drug | phaeophytin-a | 5.78e-05 | 105 | 212 | 7 | CID005351507 | |
| Drug | sophocarpine | 6.42e-05 | 9 | 212 | 3 | ctd:C035933 | |
| Drug | 0179445-0000 [211246-22-9]; Down 200; 10uM; PC3; HT_HG-U133A | 7.31e-05 | 189 | 212 | 9 | 3733_DN | |
| Drug | 0317956-0000 [391210-11-0]; Down 200; 10uM; MCF7; HT_HG-U133A | 7.62e-05 | 190 | 212 | 9 | 3966_DN | |
| Drug | Meclozine dihydrochloride [1104-22-9]; Up 200; 8.6uM; MCF7; HT_HG-U133A | CEACAM5 HNF4A NDRG2 JAK3 SERPINB9 SH3TC1 SEMA6A DMPK SIGLEC7 | 8.25e-05 | 192 | 212 | 9 | 5607_UP |
| Drug | A-39 | 8.63e-05 | 2 | 212 | 2 | CID003024589 | |
| Drug | Haloperidol [52-86-8]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 9.29e-05 | 195 | 212 | 9 | 1539_UP | |
| Drug | Natamycin [7681-93-8]; Up 200; 6uM; MCF7; HT_HG-U133A | 9.66e-05 | 196 | 212 | 9 | 7167_UP | |
| Drug | Hydrochlorothiazide [58-93-5]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 9.66e-05 | 196 | 212 | 9 | 4970_UP | |
| Drug | rosiglitazone; Up 200; 10uM; MCF7; HT_HG-U133A_EA | NR2F6 CEACAM6 GLYR1 INPP5E CHAF1A SLC1A5 SLC4A2 CASK TRAPPC10 | 1.00e-04 | 197 | 212 | 9 | 1071_UP |
| Drug | Benfotiamine [22457-89-2]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 1.00e-04 | 197 | 212 | 9 | 3837_DN | |
| Drug | Diphenidol hydrochloride [3254-89-5]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 1.00e-04 | 197 | 212 | 9 | 7447_UP | |
| Drug | Diltiazem hydrochloride [33286-22-5]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 1.00e-04 | 197 | 212 | 9 | 5309_UP | |
| Drug | Indapamide [26807-65-8]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 1.00e-04 | 197 | 212 | 9 | 3859_UP | |
| Drug | Propidium iodide [25535-16-4]; Down 200; 6uM; MCF7; HT_HG-U133A | NR2F6 PHKB NBEAL2 RECQL5 NCAPD2 REX1BD DIS3 PPP2R1B TRAPPC10 | 1.00e-04 | 197 | 212 | 9 | 6277_DN |
| Drug | Practolol [6673-35-4]; Up 200; 15uM; MCF7; HT_HG-U133A | 1.00e-04 | 197 | 212 | 9 | 5664_UP | |
| Drug | Solasodine [126-17-0]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 1.00e-04 | 197 | 212 | 9 | 3924_DN | |
| Drug | Oxymetazoline hydrochloride [2315-02-8]; Up 200; 13.4uM; HL60; HG-U133A | 1.04e-04 | 198 | 212 | 9 | 1431_UP | |
| Drug | Oxybenzone [131-57-7]; Up 200; 17.6uM; PC3; HT_HG-U133A | 1.04e-04 | 198 | 212 | 9 | 6309_UP | |
| Drug | Atropine-N-oxide hydrochloride [4574-60-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 1.04e-04 | 198 | 212 | 9 | 2216_UP | |
| Drug | Zaprinast [37762-06-4]; Up 200; 14.8uM; PC3; HT_HG-U133A | 1.04e-04 | 198 | 212 | 9 | 6749_UP | |
| Drug | Fluocinonide [356-12-7]; Down 200; 8uM; MCF7; HT_HG-U133A | 1.04e-04 | 198 | 212 | 9 | 3839_DN | |
| Drug | Thyroxine (L) [51-48-9]; Up 200; 5.2uM; MCF7; HT_HG-U133A | 1.08e-04 | 199 | 212 | 9 | 3249_UP | |
| Drug | Aminophylline [317-34-0]; Up 200; 9.6uM; MCF7; HT_HG-U133A | CEACAM5 CEACAM3 CEACAM6 CHRNA2 ITPR1 FANCA NBEAL2 RECQL5 SHANK2 | 1.08e-04 | 199 | 212 | 9 | 5395_UP |
| Drug | Adenosine 5'-monophosphate monohydrate [18422-05-4]; Up 200; 11uM; MCF7; HT_HG-U133A | 1.08e-04 | 199 | 212 | 9 | 5359_UP | |
| Drug | 5230742; Down 200; 17uM; MCF7; HT_HG-U133A_EA | NR2F6 CPPED1 CEACAM6 GLYR1 NFKBIE CLEC16A VCPIP1 SLC1A4 TRAPPC10 | 1.08e-04 | 199 | 212 | 9 | 862_DN |
| Drug | Nalidixic acid sodium salt hydrate; Up 200; 14.6uM; PC3; HT_HG-U133A | NR2F6 CDHR2 CEACAM3 ABCA7 CEACAM1 GLYR1 CACNB3 SLC1A4 TRAPPC10 | 1.08e-04 | 199 | 212 | 9 | 7367_UP |
| Drug | Prednisolone [50-24-8]; Up 200; 11uM; MCF7; HT_HG-U133A | 1.08e-04 | 199 | 212 | 9 | 5526_UP | |
| Drug | Clopamide [636-54-4]; Up 200; 11.6uM; HL60; HG-U133A | 1.08e-04 | 199 | 212 | 9 | 1605_UP | |
| Drug | Tolbutamide [64-77-7]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 1.08e-04 | 199 | 212 | 9 | 2320_UP | |
| Drug | Letrozole [112809-51-5]; Down 200; 14uM; MCF7; HT_HG-U133A | 1.13e-04 | 200 | 212 | 9 | 4824_DN | |
| Drug | Diflunisal [22494-42-4]; Up 200; 16uM; PC3; HG-U133A | 1.13e-04 | 200 | 212 | 9 | 1908_UP | |
| Disease | Renal Cell Carcinoma | 3.83e-06 | 128 | 209 | 8 | C0007134 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 3.83e-06 | 128 | 209 | 8 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 3.83e-06 | 128 | 209 | 8 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 3.83e-06 | 128 | 209 | 8 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 3.83e-06 | 128 | 209 | 8 | C1306837 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 1.12e-05 | 148 | 209 | 8 | C0279702 | |
| Disease | Malignant neoplasm of breast | EPOR NR2F6 OBSCN ETS2 PHKB FASN SULF2 NFKBIA NLRC5 ADGRF4 TIMELESS FGD5 HERC2 DMD ANK1 LAMA2 EDNRB N4BP2 CHEK2 NUP133 ZBTB3 | 2.80e-05 | 1074 | 209 | 21 | C0006142 |
| Disease | Bartter disease type 4B | 4.99e-05 | 2 | 209 | 2 | cv:C4310805 | |
| Disease | BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS | 4.99e-05 | 2 | 209 | 2 | 613090 | |
| Disease | BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS | 4.99e-05 | 2 | 209 | 2 | C4310805 | |
| Disease | Bartter disease (implicated_via_orthology) | 4.99e-05 | 2 | 209 | 2 | DOID:445 (implicated_via_orthology) | |
| Disease | Bartter disease type 3 (implicated_via_orthology) | 4.99e-05 | 2 | 209 | 2 | DOID:0110144 (implicated_via_orthology) | |
| Disease | BARTTER SYNDROME, TYPE 4B | 4.99e-05 | 2 | 209 | 2 | C2751312 | |
| Disease | Bartter disease type 4b (is_implicated_in) | 4.99e-05 | 2 | 209 | 2 | DOID:0110146 (is_implicated_in) | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 8.18e-05 | 145 | 209 | 7 | DOID:1289 (implicated_via_orthology) | |
| Disease | Intellectual Disability | PEX6 FASN ADPRS FBXW11 NSF INPP5E TTI2 SLC1A4 SHANK2 SERAC1 HTT | 3.73e-04 | 447 | 209 | 11 | C3714756 |
| Disease | Duchenne and Becker Muscular Dystrophy | 4.92e-04 | 5 | 209 | 2 | C3542021 | |
| Disease | Becker Muscular Dystrophy | 4.92e-04 | 5 | 209 | 2 | C0917713 | |
| Disease | clonal hematopoiesis mutation measurement | 6.29e-04 | 55 | 209 | 4 | EFO_0020949 | |
| Disease | Lung Neoplasms | 6.37e-04 | 265 | 209 | 8 | C0024121 | |
| Disease | Malignant neoplasm of lung | 6.53e-04 | 266 | 209 | 8 | C0242379 | |
| Disease | urate measurement | PCNX3 MFHAS1 IQCF1 ESRP1 HNF4A KCNK9 STAB1 MYO18B VARS1 R3HDM2 PPP2R1B IGF2BP2 ANKRD33 SHANK2 TMEM275 RORC | 6.85e-04 | 895 | 209 | 16 | EFO_0004531 |
| Disease | diffuse scleroderma (is_marker_for) | 7.35e-04 | 6 | 209 | 2 | DOID:1580 (is_marker_for) | |
| Disease | Bartter syndrome | 7.35e-04 | 6 | 209 | 2 | cv:C0004775 | |
| Disease | Muscular Dystrophy, Duchenne | 7.35e-04 | 6 | 209 | 2 | C0013264 | |
| Disease | episodic ataxia type 6 (implicated_via_orthology) | 7.35e-04 | 6 | 209 | 2 | DOID:0050994 (implicated_via_orthology) | |
| Disease | extracellular sulfatase Sulf-2 measurement | 1.02e-03 | 7 | 209 | 2 | EFO_0801596 | |
| Disease | Muscular Dystrophy | 1.36e-03 | 8 | 209 | 2 | C0026850 | |
| Disease | mitral valve prolapse (is_implicated_in) | 1.74e-03 | 9 | 209 | 2 | DOID:988 (is_implicated_in) | |
| Disease | Endomyocardial Fibrosis | 1.74e-03 | 9 | 209 | 2 | C0553980 | |
| Disease | aspartate aminotransferase measurement | MFHAS1 OBSCN WDR55 ITPR1 HMCN2 SH3TC1 FCGRT NLRC5 CLEC16A VARS1 CNTFR SUN1 RNF213 R3HDM2 CHEK2 | 2.08e-03 | 904 | 209 | 15 | EFO_0004736 |
| Disease | nephrogenic diabetes insipidus (implicated_via_orthology) | 2.16e-03 | 10 | 209 | 2 | DOID:12387 (implicated_via_orthology) | |
| Disease | Aortic Aneurysm, Abdominal | 2.16e-03 | 10 | 209 | 2 | C0162871 | |
| Disease | tongue squamous cell carcinoma (is_marker_for) | 2.28e-03 | 37 | 209 | 3 | DOID:0050865 (is_marker_for) | |
| Disease | hematocrit | UBAP2 PEX6 HNF4A ITPR1 STAB1 MET CLCNKB FCGRT KCNN4 FGD5 CHAF1A R3HDM2 EDNRB SLC4A2 ANKRD33 HYDIN | 2.39e-03 | 1011 | 209 | 16 | EFO_0004348 |
| Disease | Copper-Overload Cirrhosis | 2.63e-03 | 11 | 209 | 2 | C1876165 | |
| Disease | congestive heart failure (is_marker_for) | 2.78e-03 | 82 | 209 | 4 | DOID:6000 (is_marker_for) | |
| Disease | apolipoprotein B measurement | DCHS2 PEX6 MOSPD3 HNF4A ABCA8 FCGRT ANK1 R3HDM2 PARP10 HYDIN HTT SYMPK | 2.87e-03 | 663 | 209 | 12 | EFO_0004615 |
| Disease | non-melanoma skin carcinoma | 2.93e-03 | 265 | 209 | 7 | EFO_0009260 | |
| Disease | Diaphragmatic Hernia | 3.06e-03 | 41 | 209 | 3 | C0019284 | |
| Disease | prediabetes syndrome (biomarker_via_orthology) | 3.14e-03 | 12 | 209 | 2 | DOID:11716 (biomarker_via_orthology) | |
| Disease | hair colour measurement, hair morphology measurement | 3.14e-03 | 12 | 209 | 2 | EFO_0007821, EFO_0007822 | |
| Disease | non-histone chromosomal protein HMG-14 measurement | 3.14e-03 | 12 | 209 | 2 | EFO_0021872 | |
| Disease | Profound Mental Retardation | 3.17e-03 | 139 | 209 | 5 | C0020796 | |
| Disease | Mental deficiency | 3.17e-03 | 139 | 209 | 5 | C0917816 | |
| Disease | Mental Retardation, Psychosocial | 3.17e-03 | 139 | 209 | 5 | C0025363 | |
| Disease | Reactive Hyperemia | 3.70e-03 | 13 | 209 | 2 | C0178824 | |
| Disease | male infertility (implicated_via_orthology) | 3.70e-03 | 13 | 209 | 2 | DOID:12336 (implicated_via_orthology) | |
| Disease | Active Hyperemia | 3.70e-03 | 13 | 209 | 2 | C0333233 | |
| Disease | cholangiocarcinoma (biomarker_via_orthology) | 3.70e-03 | 13 | 209 | 2 | DOID:4947 (biomarker_via_orthology) | |
| Disease | Venous Engorgement | 3.70e-03 | 13 | 209 | 2 | C0042484 | |
| Disease | Hyperemia | 3.70e-03 | 13 | 209 | 2 | C0020452 | |
| Disease | left ventricular systolic function measurement | 3.75e-03 | 44 | 209 | 3 | EFO_0008206 | |
| Disease | adiponectin measurement | 3.91e-03 | 146 | 209 | 5 | EFO_0004502 | |
| Disease | eye disease | 3.99e-03 | 45 | 209 | 3 | EFO_0003966 | |
| Disease | anemia (is_implicated_in) | 4.30e-03 | 14 | 209 | 2 | DOID:2355 (is_implicated_in) | |
| Disease | Colorectal Carcinoma | OBSCN ABCA8 SH3TC1 ADAMTS18 DMD COL3A1 NPBWR2 POSTN PPP2R1B SIGLEC7 CHEK2 DCHS1 | 4.52e-03 | 702 | 209 | 12 | C0009402 |
| Disease | Primary Ciliary Dyskinesia | 4.52e-03 | 47 | 209 | 3 | C4551720 | |
| Disease | end stage renal disease (biomarker_via_orthology) | 4.52e-03 | 47 | 209 | 3 | DOID:783 (biomarker_via_orthology) | |
| Disease | forced expiratory volume, response to bronchodilator | EPPK1 NUP205 ADAMTS18 DNAH5 PREX1 MMS22L SLC34A2 IGF2BP2 SHANK2 | 4.66e-03 | 445 | 209 | 9 | EFO_0004314, GO_0097366 |
| Disease | mean reticulocyte volume | NUP210L MOSPD3 ABCA7 NUP205 COMMD1 PREX1 ANK1 CHAF1A GTPBP1 TEF PPP2R1B IGF2BP2 CHEK2 | 4.78e-03 | 799 | 209 | 13 | EFO_0010701 |
| Disease | Nephrosis | 4.93e-03 | 15 | 209 | 2 | C0027720 | |
| Disease | free androgen index | 5.40e-03 | 374 | 209 | 8 | EFO_0007005 | |
| Disease | pneumonia (is_implicated_in) | 5.61e-03 | 16 | 209 | 2 | DOID:552 (is_implicated_in) | |
| Disease | myocardial infarction (biomarker_via_orthology) | 5.75e-03 | 160 | 209 | 5 | DOID:5844 (biomarker_via_orthology) | |
| Disease | Vitiligo | 5.85e-03 | 101 | 209 | 4 | EFO_0004208 | |
| Disease | Bell's palsy | 6.05e-03 | 102 | 209 | 4 | EFO_0007167 | |
| Disease | hypertension (is_marker_for) | 6.33e-03 | 53 | 209 | 3 | DOID:10763 (is_marker_for) | |
| Disease | IGFBP-3 measurement | 6.66e-03 | 54 | 209 | 3 | EFO_0004626 | |
| Disease | Small cell carcinoma of lung | 6.66e-03 | 54 | 209 | 3 | C0149925 | |
| Disease | lipoprotein measurement | 6.70e-03 | 105 | 209 | 4 | EFO_0004732 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ALRALGPAHVLLLEQ | 516 | Q8N6Y0 | |
| ENTIEHLLPLFLAQL | 371 | P30154 | |
| LATHLQELGREIALP | 286 | Q6ZT62 | |
| AELLVLLVNHGQGIE | 1181 | P53355 | |
| AHGAVLLDLDQQTLP | 381 | P04920 | |
| LLDLDQQTLPGVAHQ | 386 | P04920 | |
| VNLPVDHISLILAVD | 446 | Q15758 | |
| QDRVIDGHSLVPLLQ | 431 | P51689 | |
| ALATLIHQVLEAPGV | 26 | Q9UBW8 | |
| LVVLDADTINHPAQL | 266 | P54284 | |
| VAEHILNLINESPAL | 2471 | Q8IZF6 | |
| AVLLLLALPGHDQET | 6 | Q15848 | |
| RISEILLDHGAPIQA | 286 | P16157 | |
| AEGKEVLLLVHNLPQ | 46 | P06731 | |
| AEGKEVLLLVHNLPQ | 46 | P31997 | |
| EEVQVLLDSLVHGNP | 166 | Q6PIY5 | |
| EHLGLALALNVPVFV | 291 | O00178 | |
| PTLGAILREAHLQNV | 296 | Q8IZF3 | |
| AEALLQEGELLLSPH | 451 | Q15822 | |
| PNILIASLALGDLLH | 136 | P24530 | |
| NLTPLEAQEFALHLI | 446 | Q9ULJ7 | |
| QPVGDLLIDSLQDHL | 2961 | P11532 | |
| ELLVGHLDLLPFLEQ | 96 | Q96M86 | |
| QLLLEALAGHLNEVP | 131 | Q9HCK5 | |
| RDEQILAQLLPLLHG | 731 | Q13111 | |
| NGIIHRDLKPENVLL | 341 | O96017 | |
| QENARLLTHAVPGLL | 191 | Q96NX9 | |
| LQLVVLDADTINHPA | 306 | O00305 | |
| HLELLVAVGPDVFQA | 81 | Q76LX8 | |
| ILLEQEPGGLLINHH | 346 | Q8TE60 | |
| LALGQAQEPLHSLLE | 171 | Q8IZY2 | |
| LLAQAELPAILHTEL | 386 | P01019 | |
| GQLHEVLVRPDQLEL | 46 | Q6NXG1 | |
| ADGPLETQDIIQLHI | 91 | Q9Y2K5 | |
| RLLLLLGAVLNPHEA | 26 | O60895 | |
| QPLVALVGNKIDLEH | 121 | P51157 | |
| ELFVLNAAQAALPLH | 241 | P10588 | |
| LAAQAGHVPLVSLLL | 171 | Q7Z3H0 | |
| SAALGHNILEPVVNL | 976 | Q7Z6P3 | |
| LQELVLPLVGNHEGH | 606 | Q9NYA3 | |
| ISEELAGILAQHAQP | 706 | Q86VS3 | |
| SAILDLPVLEHLFAQ | 126 | P52333 | |
| HLQLEILLDSGPCIV | 181 | Q8N6M8 | |
| VDEVFALPLAHLLQT | 136 | Q8WV74 | |
| LAAVELLLAGEHQQP | 106 | Q92621 | |
| HLNLQDSLDGIILPQ | 181 | Q9Y5E7 | |
| QLELVILQSEPHRAG | 61 | Q9NPC2 | |
| AGAFQHLPVLEELDL | 96 | A6NJW4 | |
| LGLNHEIAIDVAFLP | 756 | Q6NSI4 | |
| VDGFHPNEVALLLLA | 526 | P28039 | |
| FLLHQETLPEQLLAE | 1001 | Q8WUM0 | |
| EDVPAGTLLLQLQAH | 1866 | Q96JQ0 | |
| IHEQGLIAILDVEPQ | 826 | O14936 | |
| HPVLEELDLSQNLIG | 306 | Q5JU00 | |
| AFLLTIPENAEGHII | 181 | Q9NPJ1 | |
| IPQGLESIQIHLEAS | 2546 | Q9NU22 | |
| ATLFGIQLTEAHVPL | 311 | Q96JY0 | |
| ALLIVLGNPHVLVRD | 1141 | Q9BXT6 | |
| VFLHNISPNLELEAL | 441 | Q12791 | |
| AQIVLELVVCGLHPA | 106 | O15554 | |
| PAQLGALAHLEELDV | 151 | Q9Y4C4 | |
| ELVLQGNQIAVLPDH | 346 | Q9Y4C4 | |
| GLVVDVPALLQHDQL | 496 | Q9NRR6 | |
| PLVQAELSVLVDVLH | 1626 | Q14643 | |
| VTLHLLPGEQLLCEA | 41 | Q9C0I1 | |
| LSLAGNRIVEILPEH | 126 | Q6UXM1 | |
| ISVIHLGALEHLPEL | 91 | A6NDA9 | |
| IPLQDQHLALAILLE | 281 | O95714 | |
| ALEAQLPSVLIDELH | 161 | Q6ZRQ5 | |
| VSDLGQHPVLLALRN | 1041 | Q6ZRQ5 | |
| EIQLAVGHAPQLTEL | 776 | Q8NDA2 | |
| HISPDGVLLQVLQAN | 2501 | Q8NDA2 | |
| HLNDLENIIPFLGIG | 76 | P10620 | |
| AEGKEVLLLAHNLPQ | 46 | P40199 | |
| AVHLDQPGAVRALVL | 301 | O00221 | |
| LPLDDQVALLRAHAG | 211 | P41235 | |
| IVQHAGLAQPLRVEL | 276 | P55899 | |
| LNALVHLIEVGNGLV | 1381 | Q9H6A9 | |
| ILLGFTDHPELQALL | 16 | Q8NGJ0 | |
| RALTAHLPLGQEVNL | 606 | Q13608 | |
| LQNLLGFTPEELHAI | 446 | P15036 | |
| SLPNLHCELVGLDIQ | 76 | Q969X5 | |
| TALPEQGLDHIAENI | 121 | Q9UKB1 | |
| LSELPAIHDLHQGIL | 946 | Q6ZNL6 | |
| INELPENILLELFTH | 6 | Q9H4M3 | |
| DLRLAIALGDAVNHP | 506 | Q49A26 | |
| LGLEPRVLHALQEAA | 131 | Q9NUL7 | |
| EILHLAGLNELEVIP | 71 | Q8WVB3 | |
| LTLGLSLLHADVVPN | 96 | Q8N8J0 | |
| QLEALRAILHFIVPG | 501 | Q5S007 | |
| LLLVDQIHLGEESPL | 566 | Q9UL01 | |
| HVPNIATGEQLLEAL | 666 | P46459 | |
| VQLPAETLQELLDLH | 341 | Q9H0R5 | |
| IHPLENGEIHISLIN | 206 | P24043 | |
| LHLAVDLQNPDLVSL | 221 | P25963 | |
| LLHDALQIREQTLGP | 271 | Q6P597 | |
| IHPQELRLAGALDLS | 451 | Q96KJ4 | |
| LAEEIPLKILAHNGL | 271 | Q9Y6M1 | |
| PIDVAAHLQLLGESL | 521 | Q9UGU5 | |
| VSGIIQHIEALLARP | 461 | Q96MM6 | |
| ILDLQLALETHPALL | 101 | P47928 | |
| QVVGGLAPLLLHLQD | 1491 | Q8NDA8 | |
| GSLEALIQHLVPNVD | 41 | Q0VAM2 | |
| LQELVLPLVGNHEGH | 606 | A6NDN3 | |
| DGLFTLVLPVNIAEH | 91 | P48146 | |
| GLEPLLDLLLGVHQE | 21 | Q09013 | |
| VHDAEALIALLQEGP | 856 | Q86WI3 | |
| ALIALLQEGPHLEEV | 861 | Q86WI3 | |
| GLAQELPQHLRVLHL | 1681 | Q86WI3 | |
| LQLEHVEQELRLVGP | 1756 | Q7Z442 | |
| ELSAVSELLQHGLPQ | 651 | Q5TIA1 | |
| EDQGVHPQAALLVLT | 1056 | Q6V1P9 | |
| LAALSHPLVTGLLDQ | 6516 | Q5VST9 | |
| TLQIHLLDINDNAPV | 571 | Q9BYE9 | |
| HEQIPLSLDLQAGLD | 2266 | P42858 | |
| LPAQLHVDLQDELGV | 3516 | Q4G0P3 | |
| LLGLLCQGVDIPLHV | 241 | Q5SW24 | |
| AEGKEVLLLVHNLPQ | 46 | P13688 | |
| VPSDIAAGLALLHQQ | 231 | Q8NCG7 | |
| APLTAHGTLLVNDVL | 326 | O43323 | |
| LQELSHPNIIGLLDA | 66 | P50613 | |
| ADLELQQDLIVPLGH | 1026 | O15360 | |
| LPLEIGLHNINFSLE | 901 | P01031 | |
| PDLLNGSQLVLHGLE | 66 | P26992 | |
| HNGLRAVEVDPSLLL | 181 | P78560 | |
| EAIALINSLHPELLD | 81 | Q9NWU2 | |
| HIDAIILALPEDLQG | 586 | Q8IWF6 | |
| LQELVLPLVGNHEGH | 606 | A6NDK9 | |
| AILQALAVHLALQGE | 191 | Q9NX46 | |
| AEGKEVLLLVHNLPQ | 46 | P40198 | |
| DRAIPLVLVSGNHDI | 116 | Q9BRF8 | |
| HRALLLPELLEGVLQ | 396 | Q99698 | |
| AQIHTPVAIIELELG | 136 | Q8N668 | |
| VIHINEVVLLDAPVG | 136 | P19235 | |
| LQELVLPLVGNHEGH | 606 | P0CG33 | |
| RLGPELLAHVVNLAD | 606 | Q6NY19 | |
| LHPTIILAQQEAVEG | 16 | P02461 | |
| AVVLEIAPHALLQAV | 756 | P49327 | |
| LGELQARHPQLEAVL | 471 | Q8NFF5 | |
| SHLVLPQQDNLIALE | 1446 | Q9C0D2 | |
| VAHEEIGNILAFLVP | 216 | Q9BRL7 | |
| NLGSVEALHEVLQLP | 236 | A6NKF1 | |
| EALHEVLQLPAALRA | 241 | A6NKF1 | |
| LFIGVEVLPENLHLD | 1486 | Q6ZTR5 | |
| GDETLGQLLPHLLDQ | 1681 | Q8TE73 | |
| QGPLENDLVVHVALI | 486 | Q93100 | |
| LLPFHADVEIGQIIE | 551 | Q5VU65 | |
| EQHVQALLRASGLPV | 106 | Q53GL7 | |
| VNLAADPGLHETLLA | 86 | Q9BTY7 | |
| VQQAHVGLVPLLVDA | 676 | Q96AX9 | |
| QDVVPLHTQVLLADL | 296 | Q8NH67 | |
| TLLFIIQADAALHEP | 46 | Q8NGK4 | |
| TLLLIIQADAALHEP | 46 | Q8NGK3 | |
| LQAGAADHVRLLVPL | 186 | Q96C03 | |
| VHIDLSALNPELVQA | 1051 | P08581 | |
| IALGLLLAAPAQAHL | 11 | P17900 | |
| AFEIIHLLTGENPLQ | 96 | P46782 | |
| SIHLQLQGLVDPARE | 1186 | P26640 | |
| AHQLLDPGSLQLAVE | 51 | A6NDD5 | |
| LVLEPDAHAAVQELL | 631 | Q8N1F8 | |
| LGIGDLIPVDVNHLN | 611 | Q96JX3 | |
| LLALHGLEAVLQVVA | 196 | Q96HE8 | |
| ALNHPDTVEGLVLIN | 156 | Q9UN36 | |
| LVPLALEALVGAVHV | 246 | Q6ZNJ1 | |
| ELPLGALQASVVQHL | 1246 | Q9H6K5 | |
| ILTPEALGLHLQAAL | 126 | Q9Y6C5 | |
| PVLQAEVGDVILIHL | 101 | Q9BQS7 | |
| GLVSPELHEQLLVAE | 346 | P58107 | |
| LEQAAILARSHGLLP | 1596 | Q8TCU6 | |
| SNPLVLELQVHLGDE | 301 | Q9Y286 | |
| HLAHNLLLPVAELEG | 116 | Q10587 | |
| VLHGQSPVALDILQS | 836 | Q8TE82 | |
| ALLVLNHGAAPLLAL | 396 | Q96NU1 | |
| VQDEILAHRLGLIPI | 101 | O15160 | |
| PLSHDLILNLTQDGI | 51 | Q9BSU1 | |
| LTLGLSLLHADVVPN | 96 | A4QPH2 | |
| NVLLHQIDVLEDPAI | 71 | Q9Y2L1 | |
| EQLEVLAHLLVLPGG | 1631 | Q7RTU9 | |
| HLPNLQKEDLIDLGV | 1816 | Q9UPX8 | |
| HVLPIQARLGSIAEI | 126 | Q9BXP5 | |
| NLAQVEPLHAEILRL | 1521 | O94911 | |
| ELQQAALEGLALPHD | 621 | Q9NRA8 | |
| ALEGLALPHDLAVQA | 626 | Q9NRA8 | |
| LGVAHADLLQPVLDI | 456 | Q02040 | |
| LLSLAGDVALQQLVH | 926 | Q15021 | |
| HAPLVNSLAEVILNG | 326 | Q2KHT3 | |
| LLAFELTGQIVHALP | 486 | P51800 | |
| LLAFEVTGQIVHALP | 486 | P51801 | |
| NFHLPDLAVGTILLI | 356 | O95436 | |
| VSPLIALIQDQVDHL | 76 | O94762 | |
| VPELQGLVTEHVFLL | 3941 | Q63HN8 | |
| LLVRNILHVPADLDQ | 161 | Q9UNS1 | |
| TPGLAVHLEVLNARQ | 181 | Q8N587 | |
| ENHILPGQSIDLVAL | 281 | Q5T6F2 | |
| LNAALHPDEINIEIL | 581 | Q9Y5T5 | |
| TALVLINAHRPGLQE | 421 | P51449 | |
| LAHVGEVRAQLLELP | 206 | P50453 | |
| GLILQDLTFVHLGNP | 986 | Q13905 | |
| LHHIVLNVPAADLLQ | 271 | Q6NXR4 | |
| QPLLAGHVRSLQELE | 131 | Q96EN9 | |
| AELNPELDALLGHAL | 1091 | Q7Z4S6 | |
| IAIILEAIGLPTHDL | 431 | P43007 | |
| QLLEAHALLPAGATV | 226 | Q8WZ04 | |
| GHDQLVPVTLLAIAV | 641 | Q9H2E6 | |
| DELGSQLPQVLHVSL | 201 | O75425 | |
| AVNGILHFIDRVLLP | 1696 | Q9NY15 | |
| PAAQQLVDVDLLIHG | 1716 | Q86WI1 | |
| LVDVDLLIHGVPAQC | 1721 | Q86WI1 | |
| EGQDNPGLILLHDIL | 426 | Q8TC07 | |
| LPEHNALLVVGLALL | 56 | A0A0U1RQS6 | |
| PDVVLHNLLRNALLG | 91 | Q96JH7 | |
| SPLHNLQNLEVLDLG | 391 | Q9NYK1 | |
| DVILDLNTAHPQLLV | 296 | Q495X7 | |
| NLVGPDNVHVALSLV | 596 | O95347 | |
| NPGELLIALHNIDSV | 941 | Q92797 | |
| DIPALRVQLAGFHIL | 1236 | Q8IUG5 | |
| HGAPINSLLLVDENV | 126 | Q9H6Y2 | |
| VLGETLPEQHLQELR | 61 | Q53H54 | |
| AVGEQLLPTVEHLQL | 466 | O94901 | |
| QLHVEPLADSLLAGI | 786 | P48553 | |
| GVIHLIDQVLIPDSA | 356 | Q15063 | |
| LVLLPHVALELQFVG | 531 | Q9H091 | |
| EAGCLNPHIVLNIDL | 351 | Q8IWU5 | |
| TLLDLVPLLQHGQHD | 136 | Q9P2D8 | |
| IHNEIVTAPAFGLLL | 116 | Q9H5J0 | |
| LDLAGVIQNVIDHVP | 256 | Q96M32 | |
| NPHLVELDLTGNALE | 826 | P59046 | |
| LPQNVLDLHGLHVDE | 1686 | Q86UW6 |